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Q U ILL ON SCALPEL This section 
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
BASIC SURGICAL EXAMINATION*
In his paper in this issue of the Journal 
(page 59) Couture has pointed out that both 
the American College of Surgeons and the 
Royal Collfege of Physicians and Surgeons 
of Canada have agreed that a 2-year pro­
gram in basic surgery knowledge, com­
mon to all surgical disciplines, is needed; 
the program directors have been left to 
define the specific objectives. Couture em­
phasizes that if basic scientists are intimately 
involved with the planning and implementa­
tion, such integration would also benefit 
the primary medical school program. At 
present in most medical schools there ap­
pears to be a great gap between the teach­
ing of the basic sciences in the first 2 years 
and the clinical applications in the final 
2 years. This sharp division makes difficult 
the teaching of basic sciences in postgraduate 
surgical programs.
In 1970 the Committee on Examinations 
of the Royal College of Physicians and Sur­
geons of Canada began to investigate the 
possibilities of a mid-training examination as 
a step in the certification process in all 
surgical specialties. It was proposed that if 
all medical school information is considered 
basic to all physicians, there must be an­
other level of information basic to all sur­
geons, regardless of specialty.
The Committee on Examinations pro­
posed the creation of a basic principles 
examination in medicine, pathology and 
surgery, and, in 1973, the Principles of 
Surgery Examination Committee was created 
to explore the possibility of such an exami­
nation. The committee, composed of eight 
members, included one member nominated 
by each of the surgical specialty committees. 
Available as a resource for this examination
*Presented at the meeting of the Canadian Asso­
ciation of Clinical Surgeons, Quebec City, PQ, 
Mar. 18, 1975.
were approximately 7000 items in the 
McLaughlin Test Centre.
At its first meeting, the Principles of 
Surgery Examination Committee drafted an 
outline of the knowledge expected of each 
surgical trainee —  knowledge that seemed 
fundamental to all surgical specialties. In 
accordance with this outline 1500 multiple- 
choice questions were obtained from the 
McLaughlin Test Centre, chiefly general 
surge^j^orthopedic and urology questions 
with some medicine, pathology, ophthal­
mology and psychiatry included. At its 
second meeting, the committee selected 240 
items to create an examination that met the 
basic specifications; this number was later 
reduced to 233 items, categorized as follows:
1. Vital functions 
Shock
Resuscitation (cardiac arrest, pulmo­
nary failure, renal failure) 
Postoperative care and complications 
—  pulmonary, cardiovascular, gas­
trointestinal, neurologic and fluid- 
electrolyte (e.g., atelectasis, cardiac 
failure, ileus, hepatitis, oliguria, hy­
potension)
Thermal injury —  cold injury.
2. Body response to trauma
Surgical endocrinology —  interrela­
tions of hormones in homeostasis 
Surgical metabolism —  basic require­
ments, dosage, nutrition and starva­
tion, hyperalimentation 
Acid-base balance
Specific problems of trauma —  cranio­
facial, chest, abdomen, extremities.
3. Infections and neoplasia 
Specific infections
Local and systemic infections 
Antibiotics in clinical use 
Epidemiology of infections and cancer 
Radiation and radiation responses 
Oncology and neoplasia generally.
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4. Bleeding, coagulation, thrombosis and 
surgical immunology
Coagulation and clotting abnormalities 
Transfusion, blood, blood products 
Typing —  blood and tissue compati­
bility, histology, hematology 
Rejection and autoimmune patterns 
Immunosuppression.
5. Clinical pharmacology 
Diuretics
Synthetic hormones 
Anticancer drugs 
Anesthetic agents
Narcotics, sedatives and other mood­
changing drugs
Cardiac, autonomic and antihyperten­
sive drugs.
6. Miscellaneous 
Statistics and probability 
Genetics 
Embryology
Surgical history 
Anatomy
Clinical psychology 
Chemical toxins —  pollution.
In June 1974, this examination was first 
administered, without fee, to 461 candidates 
(general surgery, 189; cardiovascular and 
thoracic surgery, 9; neurosurgery, 25; or­
thopedics, 118; otolaryngology, 41; urology, 
60; and plastic surgery, 19). The only pre­
requisites were registration in a Canadian 
training program for at least 18 months and 
a defined area of specialty interest. The 
results were a surprise: of the 233 items, 
the average number of answers correct was 
only 131. Techniques of multiple-choice 
examination permit a 20% chance of correct 
answers merely by guessing, giving every 
candidate 48 correct answers, so the average 
candidate was credited with only 83 correct 
answers based on actual knowledge.
After the results of the examination were 
known, interest arose to develop a “cutting” 
score and to define satisfactory or unsatis­
factory performance. An attempt was made 
to score this basic examination by use of a 
reference point derived from candidates’ 
performance on final written certification 
examinations. By transposition of the results 
from the final written examination to the 
basic text of 233 items it was possible to
set the passing score at 151 items correct, 
which put the pass rate in the basic exami­
nation at 15% and the fail rate at 85% — 
an unacceptable result.
With another method, Canadian candi­
dates were selected as a reference group and 
were automatically passed at 83% (one 
standard deviation). All others were scored 
against this reference group. This automatic­
ally regulated the pass rate and related it 
to one subgroup of candidates taking the 
examination, but did not alter the fact that 
in order to pass a candidate needed only 
119 correct answers —• 48 obtainable by 
chance alone and only 72 by actual knowl­
edge. As expected, there were differences 
among the specialties, and, in accordance 
with previous experience, the poorest results 
came from candidates educated outside 
North America.
The overall performance may be attri­
buted to one or more of several factors:
1. The questions, although appropriate 
in the final certifying process, may not be 
appropriate to the basic level.
2. Residents are much more knowledge­
able on the basic elements at the completion 
of their program than at the mid-point.
3. These basic elements are not covered 
in any of the residency programs and the 
quantity of basic questions in the final 
examination is so small that it does not 
greatly affect the result of the score.
4. Knowing the examination would not 
count, the candidates put little effort into it.
5. The group was polluted by a large 
number of candidates who might not com­
plete their training.
6. Other factors not obvious at the 
time.
After the initial experience, this examina­
tion was given for a second time in 1975 
to another group of residents in training; 
the results were not significantly different, 
though some of the interspecialty differences 
became less prominent.
A third version of the basic surgical 
examination, created according to the ini­
tial specifications, was given in September 
1976. Formal registration, review of creden­
tials and payment of a fee will now be 
instituted for all examinees. The 1976 
examination is a required examination in
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some specialties and optional in others. 
The evaluation system must somehow pa­
rallel the education system and this exami­
nation is an attempt to accomplish such a 
purpose.
C. B. M u e l l e r , MD, FRCS[C]
TOXIC MEGACOLON
In this issue of the Journal (page 36) Patel 
and Stone report their experience in the sur­
gical management of patients with toxic 
megacolon at the Toronto General Hospital 
over a 16-year period. The article is note­
worthy in that the mortality rate for total 
and subtotal colectomy (mostly the latter) 
was only 5%. This is the lowest mortality 
rate for colectomy reported in a large series 
of patients with toxic megacolon and com­
pares favourably with the 4.8% mortality 
reported by Turnbull, Hawk and Weakley1 
with the ileostomy-colostomy technique 
followed by interval colectomy. The inci­
dence of toxic megacolon in patients with 
granulomatous and ulcerative colitis was 
5.7% in the series reported by Patel and 
Stone and 6.3% in the series reported by 
Turnbull, so one may conclude that the 
diagnostic criteria for patient selection were 
similar in the two groups of patients.
Turnbull has used the “blow-hole” pro­
cedure in the management of toxic mega­
colon because of sealed colonic perforations 
that leak during mobilization of the colon, 
even with the most meticulous surgical tech­
nique. The resulting fecal peritonitis causes 
death and illness in such patients.- Fecal 
spillage at operation was not avoided in the 
patients reported by Patel and Stone, since 
10 of 40 patients undergoing colectomy had 
recognized spillage at operation, although 
in two patients the spillage had occurred 
before operation. What is important is that 
the consequences of such spillage were suc­
cessfully managed, resulting in a low morta­
lity.
Readers should, however, not extrapolate 
the enviable results of colectomy reported 
by Patel and Stone to their own situation. 
The Toronto General Hospital is well 
equipped, with the supporting staff and 
facilities that make for effective manage­
ment of infections and intensive care. A 
surgeon working in a community hospital
on his own may not be able to cope with 
all the problems created by fecal spillage 
in the peritoneal cavity. Thus, local condi­
tions and resources may dictate that 
ileostomy-colostomy is still the preferred 
procedure in the management of patients 
with toxic megacolon.
Despite the enormous respect of the sur­
gical community in North America for 
Turnbull, his ileostomy-colostomy procedure 
for toxic megacolon does not seem to have 
been widely accepted.3 This may be because 
surgeons have failed to appreciate the likeli­
hood of operative fecal spillage occurring 
in patients with toxic megacolon, as pointed 
out by Turnbull, but also because anaerobic 
gram-negative sepsis can be controlled ef­
fectively. Thus, many surgeons believe that 
limited fecal spillage is not a catastrophe 
and that results comparable to those reported 
by Stone and Patel can be achieved with 
colectomy.4
0 .  G. T h ur sto n , MD, FRCS[C]
Department of surgery,
University of Alberta Hospital,
Edmonton, Alta.
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AORTIC ANEURYSMS 
AND ANGIOGRAPHY
The role of routine angiography in the man­
agement of asymptomatic abdominal aneur­
ysms remains controversial. Some1' 4 have 
advocated its use, but some vascular sur­
geons consider it unnecessary and others5' 7 
regard it as unsafe for routine study of 
such patients. Cyr and colleagues in this 
issue of the Journal (page 57) consider this 
controversy in the light of their experience 
with angiography. The mortality for elective 
resection of aneurysms is less than 7% 
compared with a mortality of 45% for re­
section of ruptured aneurysms. Patients who
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have undergone elective resection have a 
5-year survival of 60 to 65% .8' 10 Late 
deaths are related primarily to other mani­
festations of atherosclerosis. The major 
causes of death are myocardial infarction 
(in 40%), cancer (23%) and stroke (2% ).8
In considering angiography as a routine 
diagnostic aid in asymptomatic abdominal 
aortic aneurysms one should also take into 
account the information that can be ob­
tained from routine clinical examination and 
noninvasive investigation. Cyr and col­
leagues state that in 8 of 37 patients not 
operated upon the operation was deferred 
because of the angiographic findings; the 
problems were poor run-off, multilevel 
atheromatous disease and polyaneurysmal 
disease. The poor run-off would have been 
revealed by diminution in the peripheral 
pulses on clinical examination; the presence 
of an extension of the aneurysm above the 
renal vessels would have been suggested by 
a physical examination when it was not pos­
sible to get between the aneurysm and the 
xiphoid process; polyaneurysmal disease 
may have been suggested by physical exam­
ination, and routine chest radiography might 
have demonstrated dilatation of the thoracic 
and upper abdominal aorta. With respect to 
renal artery surgery, 9 of 46 patients re­
quired some form of renal revascularization. 
The 20% incidence of renal artery stenosis 
is similar to that found in other reports; 
however, only 50% of these were consid­
ered hemodynamically significant according 
to the usual criteria.11 (Cyr and colleagues 
do not indicate how many of these patients 
were hypertensive.)
There are several definite indications 
for preoperative angiography in patients 
with clinically suspected aneurysms of the 
abdominal aorta: the presence of a non- 
calcified abdominal mass not confirmed by 
ultrasound, indicating the likelihood of a 
nonaneurysmal mass with transmitted pulsa­
tions; an aneurysm extending to the xiphoid 
process on physical examination or a 
widened thoracic aorta on routine chest film, 
suggesting extension into the suprarenal 
aorta or a thoracic abdominal aneurysm; 
hypertension, indicating associated renovas­
cular disease; and symptoms suggesting in­
testinal ischemia or the finding of a high-
pitched bruit predisposing to postoperative 
colonic ischemia or intestinal angina. In ad­
dition, because of the occurrence of cases 
of clinically detectable, coexistent, aorto- 
iliac, femoropopliteal disease or polyaneur­
ysmal disease angiographic information is 
essential in planning distal reconstruction 
after resection of an aneurysm.
G. E vans, MB, FRCS
Department of surgery,
McMaster University Medical Centre,
Hamilton, Ont.
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1976 DAVIS & GECK SURGICAL ESSAY
THE DELAYED HYPERSENSITIVITY RESPONSE: 
CLINICAL APPLICATION IN SURGERY*
JOHN B. PIETSCH, M Dt and JONATHAN L. ME AKINS, MD, FRCS[C]
The detection of anergy or relative anergy by 
delayed hypersensitivity skin tests was pre­
dictive of infection and related mortality in 354 
surgical patients. Cancer or advanced age alone 
did not account for the increased morbidity and 
mortality seen in this study. Altered delayed 
hypersensitivity response is a reflection of 
abnormalities in cell-mediated immunity and 
possibly humoral or phagocytic defects, or both. 
Skin testing is of value to the clinical surgeon 
both in identifying the population at risk and in 
monitoring the immune response to therapy in 
the seriously ill patient. Failure to improve skin- 
test response may indicate underlying infection 
or malnutrition, which, if untreated, results in 
a high mortality.
La detection des etats d'anergie ou d’anergie 
relative, au moyen d’une cuti-reaction d’hyper- 
sensibilite retardee, a permis de predire I'infec- 
tion et la mortalite associee, chez 354 patients 
de chirurgie. Le cancer ou I'age avance seuls 
n'expliquent pas la morbidity et la mortalite 
accrues observees au cours de cette etude. Une 
reaction d'hypersensibilite retardee modifiee est 
I'expression d'anomalies de I’immunite cellulaire 
et, possiblement, de I'immunite humorale ou 
phagocytaire, ou des deux. La cuti-reaction est 
d’interet pour le chirurgien et lui permet d'iden- 
tifier la population menacee et de surveiller 
I'effet du traitement sur la reponse immunitaire 
chez les patients gravement malades. L'impos- 
sibilite d'ameliorer le resultat de la cuti-reaction 
peut indiquer la presence d'une infection sous- 
jacente ou d’un etat de malnutrition, qui, lorsque 
laisses sans traitement, entrainent un taux de 
mortalite eleve.
It is well known that certain surgical pa­
tients have a “susceptibility” to infectious 
complications and that, after the onset of
*From the departments of surgery, Royal Victoria 
Hospital and McGill University, Montreal, PQ 
H3A 1A1.
Supported by a grant from the Medical Research 
Council of Canada.
tWinner of the 1976 Davis & Geek Surgical 
Essay Award.
Reprint requests to: Dr. J. B. Pietsch, Department 
of surgery, Royal Victoria Hospital, 687 Pine 
Ave. W, Montreal, PQ H3A 1A1.
infection, they do poorly despite aggressive 
supportive efforts. This is attributed to ab­
normalities in host defence;1 and indeed 
delayed hypersensitivity (DH) skin testing 
in surgical patients to assess immune com­
petence has shown that patients who are 
at high risk for septic complications and 
death have depressed or absent responses 
to a battery of five recall antigens.2
The relation between host-defence mech­
anisms and infectious complications follow­
ing surgery was studied in 354 surgical 
patients who had DH skin testing and whose 
clinical courses were examined.
H isto r ic a l  R e v ie w
The DH response classically refers to the 
cutaneous reaction of erythema and indura­
tion occurring 24 to 48 hours after intra- 
dermal injection of a foreign antigen to 
which an individual has been previously 
exposed. One of the first scientific observa­
tions of this response was made by Jenner3 
in 1798: the injection of vaccinia virus into 
an individual who previously had been im­
munized against vaccinia was followed by 
the appearance of vesicles and erythema 
at the injection site, reaching a peak at 24 
to 72 hours. In 1890, Koch4 injected live 
tubercle bacilli intradermally into guinea 
pigs previously infected with tubercle ba­
cilli and observed erythema and induration 
at the injection site at 24 hours, which pro­
gressed to local tissue necrosis; in contrast, 
he did not observe this response in un­
infected animals. The former reaction was 
not dependent on the use of live bacilli, 
for either killed bacilli or extracts of the 
bacillus could elicit the same response. 
These findings provided the basis for the 
old tuberculin and purified protein derivative 
(PPD) skin tests of Mantoux that are the 
model for the DH response.
The distinction between the tuberculin- 
type reaction and the immediate hypersensi­
tivity response (e.g., the Arthus reaction) was 
made by Zinsser and Mueller5 in 1925.
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They discovered that the DH response did 
not require the presence of antibody as did 
the immediate response. Later, Landsteiner 
and Chase0 reported that it was possible to 
transfer delayed skin reactivity to picryl 
chloride in guinea pigs with peritoneal leu­
kocytes from sensitized animals, and Chase7 
discovered that response to PPD could also 
be transferred by leukocytes. The DH re­
sponse was therefore “cell mediated” and 
could not be transferred by serum, a char­
acteristic of the immediate “humoral-medi- 
ated” reactions.
The leukocyte involved in the DH re­
sponse is the T (thymus-dependent) lympho­
cyte. Not only lymphocytes but lymphocyte 
extracts (transfer factor) can transfer cu­
taneous reactivity in man.8 Furthermore, 
RNA extracted from sensitized lymphocytes, 
which differs from transfer factor, has also 
been shown to transfer cell-mediated im­
munity.9
The basis for the DH response is the 
ability of the body, in particular the T 
lymphocyte, to recognize an antigen (e.g., 
virus, bacteria or protein) as foreign. Entry 
of a foreign antigen into the body of an 
immunocompetent individual initiates a 
series of events that are independent of the 
nature of the antigen. Locally, the antigen 
combines with tissue proteins and cellular 
elements to produce a vasoactive factor. 
This permits the escape of neutrophils, 
lymphocytes and monocytes as well as 
plasma proteins from the local vessels, with 
subsequent migration to the area of the 
antigen. Opsonization of the antigen and 
phagocytosis by macrophages follow. In the 
regional lymph nodes, the development of 
pyroninophilic cells or immunoblasts occurs 
in the mid- and deep cortex. These cells 
proliferate over 4 to 5 days, then divide 
to form small lymphocytes sensitized to the 
antigen and are then released into the sys­
temic circulation.
If, later, there is contact with the same 
antigen, a different response occurs. The 
antigen is “recognized” by a few of the 
circulating sensitized lymphocytes that, on 
contact, release various chemical mediators 
or lymphokines such as neutrophil and mo­
nocyte chemotactic factors, blastogenic fac­
tor and migration inhibition factor. These
lymphokines cause many nonsensitized cells 
(primarily lymphocytes and monocytes) to 
migrate to the area and to dispose of the 
antigen and cellular debris. It is this influx 
of cells and plasma proteins over 24 to 48 
hours that causes the induration of the posi­
tive response to a DH skin test. An inter­
ruption of this chain of events could alter 
the final response. A negative skin-test re­
sponse (anergy) can result from either fail­
ure of prior exposure to the antigen or a 
variety of congenital or acquired deficien­
cies, which include serum inhibitors and 
leukocyte abnormalities. Such cellular de­
fects could result in decreased resistance to 
infection in the surgical patient.
Measurements of the DH response have 
aided the evaluation of previous exposure to 
many diseases. These infections may be 
fungal (candidiasis, trichophytosis, histo­
plasmosis, coccidiomycosis), viral (mumps), 
protozoal (leishmaniasis, echinococcosis) or 
bacterial (tuberculosis, leprosy). In each 
case the mechanism is the response of pre­
viously sensitized lymphocytes to the recall 
antigen. The frequent exposure to some of 
these diseases increases the probability that 
an individual will respond to several among 
a group of skin tests using recall antigens. 
In hospitalized patients the use of five recall 
antigens (PPD, mumps, candidin, tricho- 
phytin, streptokinase—streptodomase) will 
result in a positive response to two or more 
antigens in approximately 90% of patients 
tested.s- 9 Similar studies with recall anti­
gens have been used to assess the immune 
competence of patients.10 13
Other skin-test agents have been used. 
Chemicals such as dinitrochlorobenzene 
(DNCB) and dinitrofluorobenzene (DNFB) 
test the immune system somewhat differ­
ently. DNCB, a hapten, is absorbed from 
the skin surface and a small proportion is 
bound to tissue protein. This hapten- 
protein moiety then acts as an antigen and 
the process of local antigen recognition, cel­
lular infiltration and production of sensitized 
small lymphocytes in the regional lymph 
node occurs. After 7 to 21 days the sensi­
tized circulating lymphocytes will react 
either with the remaining antigen in the 
skin or with a challenge dose of DNCB,14 
producing a positive cutaneous response.
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sessing the competence of the entire DH 
The DNCB test has the advantage of as- 
sequence and of not relying on previous 
antigen exposure. However, because of the 
time factors involved, it is difficult to use 
frequently on the same patient.
Patients and Methods
Patients
The study group comprised 354 patients 
treated in the surgical wards and the in­
tensive care unit of the Royal Victoria 
Hospital, Montreal from July 1, 1975 to 
June 30, 1976. All available and willing 
patients were tested with the exception of 
those who were admitted for minor low-risk 
procedures (e.g., hernia repair and hemor­
rhoidectomy). Their admitting diagnoses are 
summarized in Table I; 286 (80.8%) of 
these patients underwent a major surgical 
procedure, and the remainder had either in­
operable cancer or acute illness that resolved 
with conservative management. Their ages 
ranged from 18 to 92 years (mean, 56 yr); 
70.6% were aged 50 years or older.
Skin Testing
Five recall antigens were used: PPD (1 
TU/0.1 ml, Connaught Laboratories, Wil- 
lowdale, Ont.); mumps skin-test antigen 
(undiluted, Eli Lilly Company, Indianapolis, 
IN); and candidin, trichophytin, and strepto­
kinase—streptodornase (Varidase) (1000 
U/ml, Hollister-Stier Laboratories, Missis­
sauga, Ont.). A control solution consisted 
of buffered diluent (undiluted, Hollister-Stier 
Laboratories). Syringes were prepared with 
0.1 ml of each solution just before intra- 
dermal injection.
All tests were administered by one person, 
and the diameter of induration (mm) at 24 
and 48 hours after injection was measured 
and recorded by the same observer. A skin 
test was considered positive if the indura­
tion at either reading was 5 mm or greater. 
The patients were classified according to 
their response to each of the five recall anti­
gens — normal (two or more positive), rela­
tive anergy (one positive) or anergy (no 
positive responses). If there was a response 
to the control solution, the diameter of
TABLE I.—D iagnosis
No. of patients
Diagnosis (and. %)
Neoplastic disease..................... 103 ( 29.1)
Colon................................... 44 (12.4)
Metastatic..........................  33 ( 9.3)
Other...................................  26 ( 7.4)
Biliary tract disease.................  76 (21.5)
Acid-peptic ulcer....................... 37 (10.5)
Sepsis........................................... 18 (5.1)
Gastrointestinal bleeding......... 18 (5.1)
Trauma....................................... 16 ( 4.5)
Obesity (for bypass)................  11 (3.1)
Small-bowel obstruction..........  10 ( 2.8)
Pancreatitis................................  9 (2.5)
Inflammatory bowel disease... 6 ( 1.7)
Other...........................................  50 (14.1)
Total...................................  354 (100.0)
induration was subtracted from that of each 
of the other five readings.
Of the 286 patients operated on 218 
(76.2%) were tested preoperatively; 97 were 
retested postoperatively. Sequential testing 
(more than one test) was done on 178 
(50.3%) of the 354 patients. Patients were 
assessed with respect to sepsis and mortality. 
Sepsis was defined as the presence of posi­
tive blood cultures or abscess documented 
either at operation or autopsy.
Statistical analysis was performed using 
the chi-square test.
Results
The 354 patients were divided according 
to the timing of skin testing into three 
groups: 218 tested preoperatively (group 1), 
75 tested after major trauma or surgery 
or both (group 2), and 61 tested but not 
operated upon (group 3) (Table II). Among 
the group 1 patients 26 (11.9%) had altered 
cutaneous responses and there was a signifi­
cantly higher rate of sepsis (P <  0.025) 
and death (P <  0.001) than among normal 
responders. Similarly, of the 75 patients in 
group 2, 64 (85.3%) were anergic or rela­
tively anergic with an associated high rate 
of sepsis (P <  0.001) and mortality (P <  
0.001). Among the patients in group 3 the 
incidence of sepsis and death was statis­
tically different (P <  0.001) for the 20 
(32.8%) abnormal responders compared 
with the normal responders.
Of the 178 patients tested sequentially, 
97 were tested before and after operation 
(Table III). The 83 patients with either an
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TABLE II.—M orbidity and M ortality (Initial Sk in  T est)
Group and response
No. of patients 
(and %) Sepsis (and %) Deaths (and %)
1
N *............................................................  192 (88.1) 8 ( 4.2) 6 ( 3.1)
R A .................................... ......................  14 ( 6.4) 3 (21.4) 5 (35.7)
A ..............................................................  12 ( 5.5) 2 (16.7) 4 (33.3)
2
N ....................................... ....................  11 (14.7) 1 ( 9.1) 0 ( 0 )
RA.................................... ....................  16 (21.3) 11 (68.7) 3 (18.7)
A ........................................ ....................  48 (64.0) 34 (70.8) 15 (31.2)
3
N ....................................... ......................  41 (67.2) 0 ( 0 ) 0 ( 0 )
RA.................................... ....................  4 ( 6.6) 1 (25.0) 1 (25.0)
A ........................................ ....................  16 (26.2) 4 (25.0) 7 (43.7)
*N = normal, RA = relative anergy, A = anergy.
TABLE III .—P reoperative and P ostoperative T ests
Preoperative
No.
Postoperative of patients
Septic
complications Deaths
N N ............................... . .71 0 0
N R A .............................. . 0 0 0
N A ............................... .. 3 3 3
RA N .............................. .. 6 0 0
RA R A .............................. . 3 2 2
RA A ................................. 3 1 3
A N ............................... .. 4 0 0
A R A ............................. .. 2 0 0
A A ............................... .. 5 2 3
Total 97 8 11
im p ro v e m e n t in  sk in -te s t re sp o n se  p o s to p e r- p a tien ts w h o se  re sp o n se s  w o rsen ed  p o st-
a tiv e ly  o r  co n tin u a tio n  o f  a  n o rm a l re sp o n se o p era tiv e ly , f o u r  h a d  sep tic co m p lica tio n s
h a d  n o  a s so c ia te d  in fec tio u s  co m p lic a tio n s a n d  all six  d ied .
o r  m o r ta lity . H o w ev er, in  fo u r  o f th e  eigh t T h e  in c lu s io n  o f  th e  o th e r  81 se q u en tia lly
p a t ie n ts  w h o  w ere a n e rg ic  o r  re la tiv e ly tested p a tie n ts  (firs t te s ted a fte r  m a jo r
a n e rg ic  p re o p e ra tiv e ly  a n d  h a d  n o  d iffe ren t tra u m a o r su rg e ry  o r  b o th  a n d  th o se  n o t
re sp o n se s  a f te r  o p e ra tio n , sepsis  d ev e lo p ed , o p e ra te d  o n )  d id  n o t a lte r th ese  resu lts
a n d  five  o f th e m  d ied . L ik ew ise  of th e  six (T ab le IV ) . T h ir ty  p a tien ts w ith  an e rg ic
TABLE IV.— I mmunologic R esponse: Sequential T esting
First Subsequent No. of
tests tests patients Sepsis (and %) Deaths (and %)
N N ............................... . .76 5 ( 6.6) 0 (  0 )
N R A ............................. . 0 0 ( 0 ) 0 (  0 )
N A ............................... .. 3 3 (100.0) 3 (100.0)
RA N .............................. ..21 8 ( 38.1) 0 (  0 )
RA R A ............................ .. 3 2 ( 66.7) 2 ( 66.7)
RA A ............................... .. 7 4 ( 57.1) 7 (100.0)
A N .............................. .3 0 14 ( 46.7) 2 ( 6.7)
A R A ............................. . 8 3 ( 37.5) 1 ( 12.5)
A A .................................. 30 19 ( 63.3) 20 ( 66.7)
Total 178 58 35
January 1977 THE CANADIAN JOURNAL OF SURGERY 19
TABLE V.—Effect of Malignant D isease on Immunologic Response
►
y
t
*
No. of patients
Condition (and %) Sepsis (and %) Deaths (and %)
Cancer
N .............................................  62 (60.2) 4 ( 6.4) 4 ( 6.4)
RA........................................... 12(11.6) 2(16.7) 6(50.0)
A ..............................................  29 (28.2) 14 (48.3) 11 (37.9)
No cancer
N .............................................. 182 (72.5) 5 ( 2.7) 2 ( 1.1)
RA..........................................  2 2 ( 8 .8 )  11 '50.0) 3(13.6)
A ..............................................  47 (18.7) 25 (53.2) 15 (31.9)
responses maintained an anergic response; 
sepsis developed in 63.3%, with an overall 
mortality of 66.7%. The mortality, how­
ever, was only 7.8% in those 38 patients 
with a prior anergic response whose skin-test 
responses improved, despite a 44.7% rate 
of sepsis. Similarly, a high rate of sepsis 
(60%) and death (90%) occurred in the 
10 patients whose responses initially were 
relatively anergic and whose responses did 
not improve. There were no deaths among 
the patients with relatively anergic responses 
whose responses later became normal. All 
three patients with conversion from normal 
to anergic response manifested sepsis and 
died whereas no deaths occurred in the 76 
normal responders who remained normal.
Cancer was present in 103 (29.1%) of 
the 354 patients. There was a significant 
difference (P <  0.25) in the proportion with 
anergy and relative anergy in this group 
(39.8%) and in those who did not have 
cancer (27.5%) (Table V). The presence 
of cancer did not, however, alter the in­
cidence of sepsis or the mortality in any of 
the three skin-test response groups (anergy, 
relative anergy, normal).
The effect of age on skin-test response, 
incidence of sepsis and mortality is seen in 
Table VI. In patients under 30 years of age, 
trauma contributed to the increased propor­
tion with altered responses (35.1%). Se­
quential studies indicated that in this group 
reversion to normal followed appropriate 
therapy. There is a gradual increase in the 
rate of anergy and relative anergy from 
20% in the 4th decade to 33.9% in the 
8th decade. Above 80 years of age, 62.5% 
of patients have altered skin-test responses 
with a 40.6% incidence of sepsis and a 
mortality of 37.5%. The increase in mor­
bidity and mortality is proportional to the 
increase in anergy and relative anergy.
Discussion
The distribution of cutaneous responses 
(anergy, relative anergy and normal) to ubi­
quitous recall antigens used in the 218 pa­
tients in group 1 was similar to that reported 
by Palmer and Reed,10 and reflects a typical 
hospitalized population. There was an in­
creased rate of septic complications (P <  
0.25) and mortality (P <  0.001) in the 
group with altered preoperative cutaneous 
responses.
Sequential measurements of DH response 
reflect accurately the evolution of the pa­
tients’ clinical course. Among patients with 
normal responses before operation whose 
responses remained normal after operation 
and among those whose abnormal responses 
subsequently became less so there were no 
deaths. However, among those whose re­
sponses remained abnormal and among
TABLE VI.—E ffect of Age
Age (yr)
No.
of patients A/RA, % Sepsis (and %) Deaths (and %)
30 37 35.1 5 (13.5) 1 ( 2.7)
30 — 39 25 20.0 3 (12.0) 0 ( 0 )
40 — 49 42 21.4 7 (16.7) 2 ( 4.8)
50 — 59 75 24.0 11 (14.7) 10 (13.3)
60 — 69 87 31.0 14 (16.1) 10 (11.5)
70 — 79 56 33.9 9 (16.1) 7 (12.5)
- 80 32 62.5 13 (40.6) 12 (37.5)
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those whose tests showed they were less 
responsive the mortality was 78.6%. The 
results of skin testing before and after oper­
ation in 52 patients indicated that uncom­
plicated surgery does not alter skin-test 
response13 in contrast to the report of 
Slade and associates.16 Postoperative alter­
ation in skin-test response, therefore, 
accurately indicates abnormalities in cell- 
mediated immunity.
In the patients in group 2 prior skin 
testing often was not feasible. Many were 
tested in the surgical intensive care unit 
following emergency operation. In these a 
high incidence of septic complications 
(70%) was associated with anergy or rela­
tive anergy. However, response to appro­
priate therapy, including restoration of 
adequate blood volume, nutritional support 
and aggressive treatment of infectious com­
plications, was reflected in restoration of 
cutaneous responses to normal with no sub­
sequent mortality. These findings indicate 
that the condition of the majority of these 
patients was normal before the acute process 
developed and that therefore abnormalities 
in cell-mediated immunity had been ac­
quired. Failure of improvement in cutaneous 
response in these seriously ill patients was 
associated with a high mortality.
In patients who did not require surgery 
or in whom surgery was not indicated (e.g., 
patients with metastatic carcinoma), the in­
cidence of sepsis and death was significantly 
higher in those with anergy or relative 
anergy. Many of these patients died of their 
advanced cancer and had altered cutaneous 
responses. Cancer or advanced age alone 
did not account for the increased morbidity 
and mortality.
Why should defects in cell-mediated im­
munity be associated with infectious com­
plications and a high mortality in surgical 
patients? Classically, susceptibility to viral, 
fungal and protozoal infections is increased 
in patients with altered cell-mediated im­
munity. However, the patients in this study 
were infected with organisms (e.g., Esche­
richia coli, Staphylococcus spp., Proteus 
spp.) thought to be controlled by humoral 
mechanisms. This implies that defects in­
volving both cell-mediated and humoral im­
munity may be present. Abnormalities in
lymphocyte, monocyte or neutrophil func­
tion have been implicated in decreased host 
resistance.13’ 17> 18 Defects in cellular 
metabolism may also cause a generalized 
decrease in immune response and may be 
related to nutritional deficiencies. We have 
reported elsewhere19 a close association be­
tween the state of nutrition and skin-test 
reactivity. In addition, the serum of anergic 
and relatively anergic patients has been 
shown to inhibit neutrophil and lymphocyte 
response in vitro.20' 21 Further investiga­
tion and identification of the cause or causes 
of anergy, it is hoped, will allow specific 
treatment. The role of immunotherapy with 
bacille Calmette-Guerin, levamisole, transfer 
factor or opsonin therapy remains investiga­
tional. Specific indications await controlled 
clinical trials and quantitative in vitro as­
sessment of treatment efficacy.
The detection of anergy or relative anergy 
by simple skin tests is predictive of infection 
and related mortality. Identification of these 
high-risk patients is valuable to the clinical 
surgeon. Preoperative measures directed at 
improving nutritional status and at elimin­
ating septic foci may help reduce the mor­
bidity and mortality in these patients. Skin 
testing postoperatively and sequentially 
thereafter aids in monitoring the patients’ 
response to therapy. Failure of improval of 
skin-test reactivity may indicate occult in­
fection, undrained abscess or nutritional 
deterioration.
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S E L F - A S S E S S M E N T
SESAP II QUESTION
509. The finding of increased amounts of carcinoembryonic antigen (CEA) in the 
blood
(1) suggests recurrent or residual cancer in a patient who has had a resection for 
carcinoma of the colon
(2) may be associated with sigmoid diverticulitis
(3) may be associated with certain collagen diseases
(4) provides the basis for a reliable screening test for identifying patients with 
carcinoma of the colon
For this question one or more of the answers given above is correct. Your answer should 
be:
A if only 7, 2 and 3 are correct,
B if only 1 and 3 are correct,
C if only 2 and 4 are correct,
D if only 4 is correct,
E if all are correct.
For the critique of Item 509 see page 83 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Sylla­
bus: Surgical Education and Self-assessment Program No. 2.)
when shockthreatens the lung
Solu-Medroihelps reduce pulmonary damage and Increase survival rates.
•  preserves lysosome and cell membranes, thereby preventing the release of destructive 
lysosomal enzymes3
• preserves platelets thereby reducing the risk of intravascular coagulation1
•  preserves leukocyte integrity thereby helping to maintain the pulmonary architecture1
The recovery of patients in shock is often complicated by a pattern of deteriorating pul­
monary function, commonly described as shock lung. This pulmonary insufficiency 
progresses despite restoration of haemodynamic balance and apparent stabilization of 
the acute episode.
Cinder conditions of prolonged shock, lack of oxygen at the cellular level causes 
alterations in the oxygen-carbon dioxide exchange mechanism. These 
changes in cell metabolism lead ultimately to interstitial oedema and peri­
vascular haemorrhage.1 Polymorphonuclear leukocytes aggregate in 
the pulmonary capillaries and obstruct the pulmonary vascular 
bed. As these trapped cells break down, they release lyso- 
somes, tiny subcellular particles containing proteolytic 
enzymes.1 These enzymes attack their host cell and 
go on to damage or destroy other cells.2 The re­
sulting tissue damage may not readily repair 
itself even if the shock patient survives. 
When administered in conjunction with 
standard therapeutic measures, Solu- 
Medrol exerts a protective effect 
on the lung and improves the 
patient’s chance of survival.
Prescribing information on page 24
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In the treatment of shock 
and its pulmonary 
complications
Solu-Mednol
soon enough, often enough, 
in pharmacologic doses
Dosage and Administration: In treating severe 
shock, there is a tendency in current medical 
practice to use massive (pharmacologic) doses 
of corticosteroids. (The anti-inflammatory ac­
tivity o f 1 m g of Solu-Medrol is equal to 4 mg 
or more o f hydrocortisone.)
The suggested dosage of Solu-Medrol for 
severe shock is 30 m g/kg stat and repeated in 
four hours, if necessary.
Therapy is initiated by administering Solu- 
Medrol intravenously over a period of at least 
ten minutes. In general, therapy should be con ­
tinued only until the patient’s condition has 
stabilized — usually not beyond 48 to 72 hours. 
Solu-Medrol may be given by intravenous in­
jection, by intravenous infusion, or by intra­
muscular injection. The preferred method for 
initial emergency use is intravenous injection.
Cautions: The general precautions and con­
traindications to systemic corticosteroid therapy 
should apply to the use of Solu-Medrol. How­
ever, when used for medical emergencies, or 
in shock-like states, the possible lifesaving ef­
fects must be weighed against the possible 
undesired hormonal effects. In the treatment 
of shock, Solu-Medrol should be adjunctive to 
conventional supportive therapy such as fluid 
replacement, etc. Although adverse effects as­
sociated with high-dose short-term corticoid 
therapy are uncommon, peptic ulceration 
may occur.
Supplied: As Solu-Medrol (methylprednisolone 
sodium succinate) in 40 mg and 125 mg 
Mix-O-Vials; 500 mg and 1 g vials with water 
for injection.
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CE 6996.9
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GLIMPSES OF SURGICAL HISTORY: 
M FOR MICROSCOPY
DAVID A. E. SHEPHARD
Osier was just one o f countless physicians 
who not only have relied on MICROSCOPY 
in their work but also have delighted in natural 
marvels so revealed. For Osier the micro­
scope brought a barrel o f water alive when 
he observed “ the dim outline o f some little 
creature kicking and struggling as though it 
were caught in a net”  —  a description re­
sembling that o f a microscopist who earlier 
had seen, in a scraping o f  his own teeth, 
"little animals, more numerous than all the 
people in the Netherlands, and moving about 
in the most delightful manner” .
This microscopist was van Leeuwenhoek. 
A 17th-century Dutch merchant, he invented 
the simple microscope —  and discovered red 
blood cells. Earlier another Dutchman, 
Zacharias Jansen, had discovered the prin­
ciple o f the compound microscope (he put 
two o f his father’s spectacle lenses together 
in an idle moment), and a third layman, 
Robert Hooke, curator o f London’s Royal 
Society, laid the scientific foundations o f the 
science o f microscopy with publication o f his 
classic work, “Micrographia” . These three, 
and the Jesuit, Athanasius Kircher, who saw 
“an innumerable Swarm o f Worms”  in a blood 
film taken from a patient with plague, helped 
to make the 17th century the dawning o f a 
new age o f science.
Man looked at the world in a new way. 
Moreover, new ideas were recorded publicly; 
and it is interesting that “Micrographia” was 
published in 1665, when the first two scienti­
fic journals (le Journal des Sjavans and Philo­
sophical Transactions) were created. A new 
force was at work, which found expression in 
language that all could understand. Just as 
Osier later saw “some little creature kicking 
and struggling”  in water, so Hooke trans­
mitted his delight at the real beauty of simple 
objects now transformed for man by the mi­
croscope. If so plain an object as a razor had 
an edge “like a plowed field, full o f ridges 
and furrows” , could there be any limit to the 
unfolding o f the flower o f science?
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ADJUVANT IMMUNOSTIMULATION IN MALIGNANT MELANOMA 
WITH ORAL BACILLE CALMETTE-GUERIN*
ALASDAIR B. MacGREGOR, MB, FRCS(Edin), RUDOLF E. FALK, MD, FRCS[C], SILVIO LANDI, PhD, ULO AMBUS, MD, FRCS[C], EFRAIM S. S. SAMUEL, MD and BERNARD LANGER, MD, FRCS[C], FACS
Results of the administration of oral bacille Cal­
mette-Guerin (BCG) as an adjunct to standard 
treatment in 62 patients with malignant mela­
noma indicate that this drug is of value in pre­
venting distant spread of the disease when it 
is limited to one region and in its early stages. 
BCG increases survival in patients with visceral 
metastases. In those in whom these metastases 
are surgically resectable, it inhibits the develop­
ment of further metastases. Oral BCG treatment 
does not affect the course of the disease in 
patients with massive hepatic or intracranial 
metastases.
Les resultats chez 62 patients de ('administra­
tion par voie orale du bacille Calmette-Guerin 
(BCG) comme therapie d'appoint au traitement 
courant du melanome malin indiquent que ce 
vaccin est utile pour prevenir la dissemination 
a distance de cette maladie lorsqu’elle est loca- 
iisee et dans ses premiers stades devolution. 
Le BCG prolonge la survie des patients atteints 
de metastases visceraies. Chez les patients 
dont les metastases peuvent etre soumises a 
une resection chirurgicale, il inhibe la crois- 
sance de nouvelles metastases. Le BCG admi- 
nistre par voie orale ne modifie pas 1'evolution 
de la maladie chez les patients atteints de me­
tastases massives hepatiques ou intracraniennes.
The continued interest in immunostimula- 
tion therapy for patients with solid tumours 
has prompted us to report further studies of 
malignant melanoma. In 1975 we presented 
the results of our use of adjuvant treatment 
with oral bacille Calmette-Guerin (BCG) in 
47 patients with malignant melanoma.1 We 
indicated that oral BCG was valuable in 
preventing local recurrence and dissemina­
tion from local disease, and that survival
*From the department of surgery, University of Toronto, and the Toronto General Hospital, To­
ronto, Ont.
Supported by the National Cancer Institute of Canada, the Medical Research Council of Canada and the Ontario Cancer Treatment Research 
Foundation.
Reprint requests to: Dr. R. E. Falk, Room 100, University Wing, Toronto General Hospital, To­ronto, Ont. M5G 1L7.
time was prolonged in patients with dis­
seminated melanoma without intracranial 
metastases. The survivors of this group have 
been followed for a further year and 15 new 
patients have been added. The present study 
(ending May 31, 1976) confirms the original 
observations; it further emphasizes the 
benign nature of the treatment in contrast 
to occasional serious complications en­
countered with adjuvant chemotherapy.
Administration of BCG
The BCG strain was derived from the 
original Pasteur strain produced by Con­
naught Medical Research Laboratories. The 
standard oral dose was 120 mg, reconsti­
tuted in nonbacteriostatic normal saline solu­
tion (live colony organism count, 107/m g 
moist weight) and administered to the pa­
tient in orange juice. The dosage was de­
creased if gastrointestinal side effects oc­
curred. BCG was given either weekly or 
every 2 weeks for 2 months —  the more fre­
quent dosage being used in patients with 
negative skin tests. After 2 months, the in­
terval was increased to once monthly. In pa­
tients who remained disease-free at 1 year, 
the interval between treatments was in­
creased to 3 months. If the melanoma re­
curred or obviously progressed, the interval 
between treatments was decreased.
Patient Groups
The 62 patients were divided into five 
groups depending on the stage of disease at 
the beginning of treatment: group 1, 21 
patients (9 women, 12 men; average age, 
39.8 yr) with local disease only —  stages 0, 
1 and 2 according to the M. D. Anderson 
Hospital classification; group 2, 18 patients 
(10 women, 8 men; average age, 47.9 yr) 
with metastases to regional lymph nodes or 
in transit melanoma — stage 3; group 3, l l  
patients (6 women, 5 men; average age, 
47.1 yr) with disseminated melanoma — 
stage 4, but excluding intracranial meta­
stases; group 4, 6 patients with intracranial
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metastases; and group 5, 6 patients with 
primary intraocular melanoma, with or 
without metastases.
R e su lts
Group 1
Seventeen of the 21 patients began treat­
ment with BCG within 2 months of diag­
nosis of malignant melanoma, 2 within 6 
months and 2 patients, with stage 2 disease, 
at 4 and 8 years, respectively (Table I). At 
the time of writing (May 31, 1976) all pa­
tients are alive; the mean survival from the 
start of treatment is a little less than 2 
years. The disease recurred in six patients 
during treatment, two with level 4 (stage 1) 
invasion (out of six patients), the three pa­
tients with stage 2 disease and the one with 
multifocal disease.
Axillary tumour recurred in one patient 
(no. 14) 15 months after primary excision. 
It was treated by axillary dissection (3 of 
31 lymph nodes involved) followed by in­
traperitoneal BCG and two courses of da- 
carbazine. Oral BCG was continued every 
2 weeks but after 5 months recurrent tu­
mour at the primary site required excision. 
He received a third course of dacarbazine 
but yet another axillary lesion developed 
and required excision. He has no evidence 
of distant spread.
Axillary and supraclavicular spread de­
veloped in patient 18 after 27 months of 
treatment (2 mg of BCG, intraperitoneally, 
combined with monthly courses of dacar­
bazine and oral BCG), which included a 
6-month remission. He underwent forequar­
ter amputation because of brachial plexus 
involvement, and is apparently disease-free.
In patient 15 recurrent tumour in a local 
lymph node 8 months after the start of 
therapy was treated by inguinal node dis­
section and dacarbazine. At present, he is 
apparently tumour-free.
Local recurrence occurred at two sites in 
each of two patients (nos. 19 and 20). In 
patient 19 the lesions were excised. In-
TABLE I.—P atient Data and R esults in Group 1 — Stages 0 ,1  and 2 Malignant M elanoma
Interval Recurrence
f r o m -----------------------------
diagnosis Before During 
Patient Age, Stage to BCG BCG BCG
no. Sex yr  or level treatment, mo treatment treatment
Survival, mo
From 
start of
Other From time of BCG 
treatment diagnosis* treatment]
1 M 38 Level 1 0 __ ___ __ 22 22
2 M 32 Level 1 1 — — — 36 35
31 F 27 Level 2 0 — — — 33 33
4 F 53 Level 2 0 — — — 10 10
5 F 54 Level 2 0 — — _ 28 28
6 F 18 Level 3 6 _ — — 40 34
71 F 57 Level 3 6 — — — 40 34
8 F 49 Level 3 0 — — _ 34 34
9 M 34 Level 3 1 — — _ 24 23
10 M 32 Level 3 0 — — — 19 19
11 F 39 Level 3 2 — — _ 14 12
12 M 60 Level 4 0 — _ — 34 34
13 F 18 Level 4/5 2 — _ _ 24 22
14 M 37 Level 4 1 — 3 Excision, dacarbazine, 
intraperitoneal BCG
23 22
15 M 60 Level 4 1 — 1 Excision,
dacarbazine
10 9
16 M 25 Level 4 0 — — — 5 5
17 M 41 Level 4 1 — — Dacarbazine 5 4
18 M 52 Stage 2 2 1 1 Excision, dacarbazine, 
intraperitoneal BCG
37 35
19 M 36 Stage 2 94 2 2 Autologous and 
allogeneic 
cells, excision
120 26
20 M 38 Stage 2 48 2 2 Dacarbazine 82 34
21 F 35 Multifocal 0
“
Multiple Excision,
dacarbazine
26 26
*Mean =  31.7 mo.
(Mean = 23.9 mo.
(BCG caused gastrointestinal side effects.
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guinal lymph-node biopsy gave negative re­
sults. This patient was twice treated with 
autologous and allogeneic irradiated mela­
noma cells. He is receiving oral BCG and 
has been disease-free for 5 months. In pa­
tient 20 excision was followed by monthly 
treatment with dacarbazine for 6 months in 
addition to oral BCG. He has remained free 
of disease for 13 months.
The condition of the sixth patient with 
recurrent tumour was discussed in detail 
previously.1 She had an excisional biopsy 
of the tongue in January 1974, followed 
by oral BCG treatment and hemiglossec- 
tomy in February 1974. Despite continued
treatment, local and distant recurrence de­
veloped requiring radical neck dissection 
and hemimandibulectomy in July 1974. Sec­
ondary tumour in the lung responded par­
tially to the administration of dacarbazine 
monthly and oral BCG weekly. In Septem­
ber 1975, the secondary lesion was excised, 
but 5 months later multiple lung and skin 
metastases were present and the disease is 
now out of control.
Group 2
Of the 18 patients in this group, 17 had 
regional lymph-node metastases at the start 
of treatment with BCG; 1 had in-transit
TABLE II.—Patient Data and Results in Group 2 -  Stage 3 Malignant M elanoma
Interval
fro m  Surviva l 
diagnosis f r o m  tim e  
to B C G  o f diagnosis, 
treatm ent, m o mo
N o . o f  operations
P a tien t
no. S e x
Age,
y r
B efore
B C G
trea tm ent
D u rin g
B C G
treatm ent
Other
treatm ent O utcom e
22* F 38 80 107 2 2 Autologous cells, 
dacarbazine
Died: pulmonary 
metastases
23 F 36 72 82 2 1 Dacarbazine,!
carmustine
Died: myelosuppres- 
sion causing bleed­
ing into intra­
cranial secondary
24 M 17 38 50 2 — Dacarbazine Died: liver metas­
tases
25 F 62 21 59 3 5 Dacarbazine Alive: disease stable
26 M 59 36 40 1 — None Died: intracranial 
metastases
27 F 47 24 36 2 1 None Died: pulmonary 
embolism after 
ventriculoperi­
toneal shunt
28 F 35 24 28 3 1 None Died: multiple me­
tastases
29 M 77 3 23 4 Autologous cells Initially refused 
treatment. Died: 
progressive mela­
noma
30 F 58 8 21 3 Dacarbazine Died: transient re­
missions of 2 and 
1 mo
31 M 59 9 19 2 1 Autologous and 
allogeneic cells, 
dacarbazine
Died: progressive 
disease
32 M 71 9 15 1 — None Died: multiple 
metastases
33 M 29 4 36 1 — None Alive: disease-free
34* F 47 102 111 2 — None Alive: disease-free
35 M 56 35 50 2 — Dacarbazine, Alive: disease-free
36 F 58 34 47 2 Dacarbazinef
intradermal
BCG
Alive: disease-free
37 F 35 19 23 4 — Dacarbazine,
carmustine
Died: multiple 
metastases
38 M 36 11 21 3 — Dacarbazine Died: multiple 
metastases
39 F 48 0 12 1 1 Dacarbazine,
carmustine
Alive: lymph-node 
biopsy negative. 
Disease-free
*BCG caused gastrointestinal side effects. 
|Dacarbazine caused side effects.
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metastases. The interval between initial 
diagnosis and the start of treatment (Table 
II) did not appear to affect survival.
At the time of writing six patients in this 
group are still alive; their mean survival is 
52.5 months from the time of diagnosis 
and 19.8 months from the start of BCG 
treatment. The mean survival for all patients 
in this group is 43.3 months from diagnosis 
and 13.9 months from the start of treatment, 
compared with 39.5 months and 12.2 
months respectively in our previous report.1 
Five patients had residual disease at the 
start of treatment; their average survival was 
9.4 months.
One survivor (no. 25) had five resections 
of tumour while on treatment and also re­
ceived dacarbazine. She still has slowly 
progressive local tumour but no evidence 
of dissemination. Two survivors (nos. 33 
and 34) had no other treatment and remain 
apparently free of disease. Two more (nos.
35 and 36) were treated with dacarbazine; 
patient 36 received intradermal BCG and 
dacarbazine in addition to oral BCG. This 
patient had a severe reaction to dacarbazine, 
with nausea, vomiting, diarrhea and severe 
phlebitis at the site of injection. Both pa­
tients are free of disease, as is patient 39, 
who was treated with two courses of dacar­
bazine and carmustine.
Two of the patients who were alive when 
last reported1 have since died. Patient 22, 
who had metastatic disease, died of pul­
monary metastases. Multiple skin metastases 
developed in patient 23. These were excised 
and she was treated with one course of da­
carbazine and carmustine. She died from 
hemorrhage into an unsuspected intracranial 
metastasis induced by severe myelosuppres- 
sion following the chemotherapy. The addi­
tion of other forms of treatment, such as 
chemotherapy and immunostimulation with 
autologous or allogeneic irradiated mela-
TABLE III.—P atient Data and Results in Group 3 -  Stage 4 Malignant Melanoma but Excluding
Intracranial Metastases
Patient
no. Sex
Age,
yr
Interval 
from 
diagnosis 
to BCG 
treatment, mo
Survival 
from lime of 
diagnosis, 
mo
No. of operations
Before During 
BCG BCG 
treatment treatment Other treatment Outcome
40 F 29 79 104 2 3 Chemotherapy 
before BCG, 
autologous and 
allogeneic cells
Died: progressive 
disease
41 F 61 84 107 3 2 Autologous cells, 
dacarbazine
Alive: in remission
42 M 54 84 89 2 1 Autologous cells, 
intratumour 
BCG
Died: progressive 
disease
43 F 36 50 59 4 — Intratumour
BCG
Died: progressive 
disease
44 M 60 10 46 1 1 Dacarbazine Alive: in remission
45* F 43 0 29 1 6 Autologous and 
allogeneic cells, 
dacarbazine
Died: progressive 
disease
46 F 20 20 29 2 3 None Died: progressive 
disease
Died: progressive 
disease
47 M 59 4 6 3 — None
48 M 74 0 4 — — Intratumour
BCG
Died: progressive 
disease
49 F 42 114 117 2 Dacarbazine,) 
carmustine, in­
tradermal 
BCG
Died: myelosuppres- 
sion, minimal re­
sidual disease
50 M 40 17 26 2 1 Dacarbazine, 
carmustine, 
intradermal 
and intraperi- 
toneal BCG
Died: progressive 
disease
*BCG caused gastrointestinal side effects. 
(Dacarbazine caused side effects.
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noma cells, does not appear to have pro­
longed survival in this group.
Group 3
All 11 patients in this group (Table III) 
had disseminated melanoma at the start of 
treatment with BCG. Five had visceral 
spread, two had spinal metastases and in 
the remaining four the disease had spread 
beyond the regional lymph nodes. Mean 
survival was 56 months from the time of 
diagnosis and 14 months from the start 
of treatment with BCG.
Nine patients died, seven as previously 
reported1 from progressive disease. The 
two new patients added to this group both 
died; in patient 49 the disease had spread 
to the ipsilateral supraclavicular lymph 
nodes from a primary melanoma in the arm. 
She was treated with two courses of dacar- 
bazine and carmustine as well as oral and 
intradermal BCG. The second course was 
followed by severe myelosuppression, sys­
temic candidiasis and death from massive 
hemoptysis. There were small foci of mela­
noma in the supraclavicular glands only. 
The other patient (no. 50) started BCG 
treatment after resection of bony metastases 
from the lumbar spine with spinal fusion 
and radiotherapy. He failed to respond to 
treatment with dacarbazine and carmustine 
as well as oral, intradermal and intraperito- 
neal BCG. He required a second laminec­
tomy and spinal fusion for pain and eventu­
ally died of metastatic melanoma.
There were two survivors from the 
original series (nos. 41 and 44). Patient 41 
had deposits in the leg requiring resection 
and two courses of dacarbazine. She re­
mains free of disease and is receiving oral 
BCG only. Patient 44 had a resection of 
supraclavicular lymph nodes and one 
course of dacarbazine. He also remains free 
of disease and is receiving oral BCG.
Groups 4 and 5
The patients with intracranial metastases 
in group 4 were previously reported1 and 
no new patients were added to this group. 
The addition of oral BCG treatment in this 
group had no influence on survival (mean, 
5.3 mo from the start of BCG treatment).
One new patient with intraocular mela­
noma with metastases was added to group 5. 
The previous five patients all died (mean 
survival, 2.4 mo from the start of treat­
ment); the cause of death in all was hepatic 
metastases. The new patient is a 60-year- 
old man who had had enucleation for intra­
ocular melanoma 7 years previously. A 
chest wall mass was resected; it was a sec­
ondary melanoma involving the fourth rib 
and surrounding muscle. After operation, 
he was treated with dacarbazine, carmustine, 
and intraperitoneal BCG (2 mg); subsequent­
ly he received maintenance therapy with oral 
BCG. He has remained free of disease for 
11 months.
D iscussion
Nonspecific immunostimulation in the 
management of patients with malignant 
melanoma is becoming established. A re­
cent report by Eilber and colleagues2 re­
vealed that in patients with stage 2 malig­
nant melanoma, the combination of opera­
tion and BCG treatment was superior to op­
eration alone, both in decreasing the propor­
tion of patients in whom recurrence devel­
ops by up to 50% and in delaying the on­
set of metastases by a mean of 6 months. 
Treatment was less effective in those with 
jnultiple lymph-node involvement.
An alternative method of treatment is 
limb perfusion with hyperthermia, recently 
reported by Stehlin and associates.3 This 
method produced a 5-year survival rate of 
83.5% in stage 1 disease. In patients with 
regional recurrence or metastases clinically 
confined to an extremity, the 5-year survival 
rate was 48.2%. This method is limited to 
melanoma of the extremities and would not 
have been applicable in 10 of our group 1 
patients who had melanoma of the trunk or 
head and neck.
In none of our patients with' level 1 to 
3 (stage 1) disease has a recurrence de­
veloped (mean follow-up, 25.8 mo). Only 
two of six with level 4 invasion have 
had recurrent disease; in one the disease 
has spread to the supraclavicular nodes. In 
the patient with multifocal disease, pul­
monary metastasis became apparent 8 
months after the treatment began, but was 
well controlled by a combination of oral 
BCG and dacarbazine; the lesion was re­
sected 13 months later. Thus it appears that
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oral BCG is useful in limiting the dissemina­
tion of tumour beyond the primary region 
in patients with stages 1 and 2 malignant 
melanoma. These findings agree with those 
of Eilber and colleagues,- who administered 
Tice strain of BCG intradermally.
Of the 17 patients in group 2 with lymph- 
node involvement, 10 had melanoma of the 
trunk or head and neck. The patient with in­
transit metastases had melanoma of the leg. 
All the patients who died had metastatic 
disease. One patient died as a consequence 
of myelosuppression, which led to bleeding 
into an unsuspected intracranial metastasis. 
In each patient with lymph-node involve­
ment melanoma had invaded many nodes, 
placing these patients at high risk of early 
recurrence. Treatment with oral BCG with 
or without chemotherapy resulted in a mean 
survival of 19.8 months (range, 9 to 38 mo) 
in the six who are still alive, all but one of 
whom are free of disease.
In group 3, patients with disseminated 
melanoma but no intracranial metastases, 
the mean survival was 14 months compared 
with 4 months reported by Einhorn and col­
leagues.4 Two patients out of 11 are alive 
at 23 and 36 months. Both required further 
resection and treatment with chemotherapy 
in addition to oral BCG; both had local or 
regional nodal recurrences. This finding in­
dicates further that, in some patients, oral 
BCG is effective in preventing distant 
metastases.
Our previous results showed that BCG 
did not affect the course of patients with 
intracranial or massive hepatic metastases. 
In the one patient with a solitary chest wall 
recurrence from intraocular melanoma, a 
combination of chemotherapy and oral and 
intraperitoneal BCG controlled the disease.
The results obtained in this series and 
that of Eilber and colleagues- show that 
adjunctive treatment with BCG is effective 
in controlling recurrence and dissemination
of malignant melanoma. It is of greatest 
value in the early stages when all the tumour 
can be resected but is also of use when the 
tumour burden has been reduced to a mini­
mum or eliminated by surgery in patients 
with metastases. Oral administration is easy 
and has minimal side effects. The results 
are comparable to those achieved by the 
intradermal route. The intraperitoneal route 
has been used without side effects in four 
patients to reinforce oral BCG. Three pa­
tients have received intradermal BCG with­
out any obvious improvement in survival.
It is difficult to assess the effect of the 
addition of chemotherapy to the treatment 
regimen in this series of patients, although 
favourable results have been reported by 
Gutterman and associates.5 While dacar- 
bazine alone produced a severe reaction in 
only 1 of 17 patients, the combination of 
carmustine and dacarbazine caused severe 
myelosuppression in 2 of 6 patients. This 
combination did not influence survival in 
the few patients in whom it was used and 
therefore should be used with extreme 
caution.
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Correction
On page 557 of the November 1976 issue of the Journal the legend for the photograph 
of the presentation of the first Davis & Geek Surgical Essay Award should read “Mr. 
Dave Smith, marketing manager of Davis & Geek, Division of Cyanamid of Canada 
Limited, presents a cheque . .
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SPONTANEOUS AORTOCAVAL FISTULA SECONDARY TO RUPTURED  
ABDOMINAL AORTIC ANEURYSM*
A. S. LIVINGSTONE, MD, C. I. CHIU, MD, PhD, FRCS[C], D. S. MULDER, MD, FRCS[C] and H. J. SCOTT, MD, FRCS[C]
Two patients with the rare condition of sponta­
neous aortocaval fistula secondary to ruptured 
abdominal aortic aneurysm were treated suc­
cessfully by surgical closure of the fistula. In 
view of the existing controversies on certain 
aspects of the pathophysiology involved, canine 
experiments were performed to elucidate the 
pathogenesis of regional venous hypertension 
and hematuria observed in these patients. The 
experiments demonstrated that regional venous 
hypertension is a purely rheologic phenomenon 
and that hematuria originates from a congested 
lower urinary tract.
Deux patients presentant une affection rare, une 
fistule aorto-cave spontanee secondaire a la 
rupture d'un anevrisme de I’aorte abdominale, 
ont ete traites avec succes par fermeture chirur- 
gicale de la fistule. Vu la controverse actuelle 
concernant certains aspects de la pathophysio- 
logie impliquee, des experiences chez des 
chiens ont ete effectuees dans le but d’elucider 
la pathogenese de ('hypertension veineuse re­
gional et de I’hematurie observees chez ces 
patients. Ces essais ont demontre que I'hyper- 
tension veineuse regionale est un phenomene 
purement rheologique et que I’hematurie pro- 
vient d'une congestion du tractus urinaire infe- 
rieur.
Sp o n t a n e o u s  aortocaval fistula, though 
relatively rare, is an often fatal complication 
of abdominal aortic aneurysm.1"8 We 
report the successful management of this 
condition in two patients by emergency 
operation and describe the results of an 
experimental study that appears to resolve 
existing controversies related to the patho­
physiology of this condition.
Case R eports
Case 1.—A previously healthy 62-year-old man complained of the sudden onset of severe
*From the division of cardiovascular and thoracic surgery, department of surgery, McGill University, Montreal General Hospital, Montreal, PQ. 
Supported by grants from the Medical Research Council of Canada.
Reprint requests to: Dr. C. J. Chiu, Division of cardiovascular and thoracic surgery, Montreal General Hospital, 1650 Cedar Ave., Montreal, PQ 
H3G 1A4.
right-sided flank pain that spread down the right leg; a few hours later the left leg became 
uncomfortable. Both legs were swollen and 
appeared bluish as did the pelvis and lower 
abdomen. Hematuria was noted on admission. 
His blood pressure was 160/60 mm Hg and 
the pulse rate 130 beats/min. Physical exam­
ination revealed a pulsating mass in the mid­
abdomen that was not readily palpated at 
first owing to obesity; the abdomen was not 
tender. Peripheral pulses were strong. There 
was no sign of ischemia but venous engorge­
ment of the legs was evident beginning just 
below the umbilicus and involving both lower 
extremities. The distended leg veins did not 
collapse when the legs were elevated. A Foley 
catheter drained large quantities of bloody 
urine. The central venous pressure was 0 to 2 cm H2iO. Intravenous pyelography demon­
strated normally functioning kidneys with dis­
placement of the right ureter laterally by a 
mass. Angiography revealed an abdominal aortic aneurysm with a fistula to the inferior vena cava (Fig. 1).
Fig. 1.—Case 1. Aortogram (lateral view) dem­onstrating contrast media in aortic aneurysm and inferior vena cava.
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At laparotomy we found an aortic aneurysm 
(length, 15 cm) below the renal arteries and 
a fistula (length, 4 cm) extending from the 
aneurysm into the inferior vena cava just above 
the level of the bifurcation. Proximal and 
distal aortic clamps were applied and the 
aneurysm was entered; digital pressure con­
trolled caval bleeding. The fistula was closed 
from within the aneurysm. A woven Dacron 
prosthesis was inserted from the infrarenal 
aorta to both external iliac arteries. The hema­
turia had cleared by the end of the procedure 
and the postoperative course was uncom­
plicated.
Case 2 .—A 57-year-old man with no per­
tinent previous medical history was admitted 
with increasingly severe, nonradiating, low 
back pain for 2 days and gross hematuria. 
Swelling of both legs was first noted 24 hours 
before admission. His blood pressure was 
130/SO mm Hg and his pulse rate 100 
beats/min. An abdominal aortic aneurysm was 
palpated in the midline extending towards the 
right lower quadrant. There was local tender­
ness. A continuous grade 4/6 bruit was heard, 
loudest in the right lower quadrant. All peri­
pheral pulses were strong. There was severe 
venous congestion and edema of both legs. The 
diagnosis of aortocaval fistula was made from 
the clinical findings alone. At operation an 
aneurysm (length, 13 cm) below the renal ar­
teries extended bilaterally into the iliac arteries. 
A fistula (length, 4 cm) extended from the 
aneurysm at the bifurcation into the right com­
mon iliac vein at its junction with the inferior 
vena cava. The fistula was closed as described 
in Case 1 and the aneurysm was replaced with 
a bifurcated Dacron aortobifemoral graft. The 
postoperative period was uneventful except for 
a period of hypertension soon after the opera­
tion; the hypertension was controlled initially 
by an intravenous nitroprusside infusion and 
subsequently with methyldopa (Aldomet).
Comment
Spontaneous aortocaval fistula secondary 
to ruptured abdominal aortic aneurysm is 
relatively rare, approximately 50 cases 
having been reported in the literature.1 In 
one series of approximately 1400 abdominal 
aortic aneurysms surgically managed (of 
which 130 had already ruptured),2 four 
aortocaval fistulas were encountered. These 
patients usually present with a unique syn­
drome of a pulsatile abdominal mass and 
marked regional venous hypertension involv­
ing both lower extremities and the lower 
abdomen. They complain of low back, ab­
dominal and occasionally leg pains and 
often have gross or microscopic hematuria. 
The prognosis of untreated patients with 
such fistulas is poor.1 3- 4 Although they 
may eventually die from heart failure due to 
the massive arteriovenous shunt, the venous 
hypertension appears to be confined initially 
to the lower extremities and the pelvis.
To explain these findings, a number of 
authors have postulated that the bulging 
aortic aneurysm cephalad to the aortocaval 
fistula compresses the vena cava above the 
fistula, directing the shunt flow towards the 
lower extremities.5’ 6 It was argued that 
such a phenomenon is peculiar to the aorto­
caval fistula secondary to the ruptured ab­
dominal aortic aneurysm, and that patho- 
physiologically it differs from traumatic 
aortocaval fistula. The pathogenesis of 
hematuria was also debated. DeBakey and 
colleagues7 studied renal function before 
and after the repair of aortocaval fistulas. 
The fistulas decreased the renal plasma flow 
substantially, although the glomerular filtra­
tion fraction was increased and thus the glo­
merular filtration rate remained normal. On 
the other hand, in patients with spontaneous 
aortocaval fistula associated with abdominal 
aortic aneurysm, the gross and microscopic 
hematuria had been attributed to severe 
pelvic venous hypertension, implicating the 
lower urinary tract as the source of hema­
turia.8 In view of such controversies, we 
performed canine experiments to determine: 
(a) the pressure gradient in the inferior vena 
cava in the presence of a large aortocaval 
fistula without aneurysm and (b) the source 
of hematuria.
Canine Experiments
Three mongrel dogs (weight, 18 to 20 kg) 
were anesthetized with intravenous pento­
barbital (30 mg/kg) and intubated. A poly­
ethylene catheter was advanced into the 
inferior vena cava through the right saphen­
ous vein and connected to a Statham strain 
gauge and a Grass recorder. The right ureter 
was cannulated through a midline lapar­
otomy incision, with the tip of the catheter 
in the right renal pelvis; the ureter was
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F=Fistula B=Urinary Bladder
Fig. 2.—Canine experimental model and results, illustrating pressure gradient in inferior vena cava and development of hematuria from lower urinary tract.
ligated and divided at the ureteropelvic 
junction. Another catheter was placed into 
the urinary bladder through a suprapubic 
cystostomy. Urine from both the right kid­
ney and the bladder was collected in sep­
arate tubes and observed for the appearance 
of hematuria. A portion of the infrarenal 
abdominal aorta (length, 1.8 cm) was anas­
tomosed side to side to the inferior vena 
cava. Pull-through pressure recordings were 
obtained in the inferior vena cava: the 
caval catheter was advanced to the level of 
the diaphragm and, under continuous pres­
sure monitoring, was gradually withdrawn 
towards and below the fistula. Fig. 2, re­
presenting a tracing obtained from such 
pressure monitoring, shows normal venous 
pressure in the inferior vena cava above the 
fistula, a slight decrease in the venous pres­
sure with turbulence just above the level 
of the fistula and a sharp increase of inferior 
vena caval pressure, becoming identical to 
the aortic pressure, when the catheter 
tip reached the level of the fistula and 
below. These pressure changes were con­
firmed by the visual observation of the in­
ferior vena cava, which was normal and 
collapsing above the fistula and distended 
and pulsating below.
Urine from both the right kidney and the 
bladder was clear before the establishment 
of the aortocaval fistula. Within minutes to
hours, blood appeared in the bladder urine 
with congestion and edema of the ureter 
and urinary bladder, whereas urine from the 
right kidney remained clear. Occlusion of 
the aorta proximal to the fistula cleared the 
urine of blood within a short period of time. 
At autopsy, the kidneys were not congested, 
whereas the pelvic organs were edematous 
with intramucosal hemorrhage in the ureter 
and urinary bladder.
D iscussion
Although the hypothesis that the aortic 
aneurysm compresses the vena cava above 
the fistula and causes shunt flow to be 
directed towards the lower extremities is 
plausible, no direct proof has been demon­
strated.50 The initial clinical impression 
that such regional venous hypertension is 
unique and is not seen in traumatic aorto­
caval fistula has not been substantiated by 
recent observations.1 There has been no 
angiographic confirmation of caval com­
pression either in our patient or in those 
reported previously. Nor have we been im­
pressed by clinical signs of inferior vena 
caval compression in other patients with 
large abdominal aortic aneurysms.
Our experimental study clearly indicates 
that the phenomenon of regional venous hy­
pertension in the lower extremities is pri­
marily hemodynamic. The great velocity of 
blood flow in the aorta and the parallel ana­
tomical arrangement of the aorta and the 
vena cava direct the blood flow caudad to­
wards the veins in the lower extremities as a 
purely rheologic phenomenon. The slight de­
crease in the pressure and the turbulence 
just above the fistula that we observed is 
consistent with such a rheologic concept. 
Furthermore, our experiments indicate that 
the renal veins are protected from abnormal­
ly high pressure, and the hematuria indeed 
originated from the congested lower urinary 
tracts. Therefore we conclude that there is no 
basic pathophysiologic difference between 
traumatic aortocaval fistula and fistula asso­
ciated with an aortic aneurysm. The different 
clinical courses described in the past5 can be 
attributed to the size of the fistula, the dif­
ference in age of the patients in the two 
groups and the condition of the cardio-
IVC PRESSURE
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vascular system, since the spontaneous 
aortocaval fistula secondary to aortic aneur­
ysm occurs mostly in elderly patients with 
advanced arteriosclerosis. The average sur­
vival of patients with spontaneous aorto­
caval fistula not treated surgically is 
approximately 20 days (range, 2 h to 2 
mo).1
Clinical awareness of this unique syn­
drome can lead to prompt diagnosis, often 
from clinical findings alone, and early sur­
gical intervention should save many of these 
patients.
We thank Dr. Milton J. Herba, radiologist, who 
performed the aortography.
R eferences
1. Symes JM, E adie DG, M acLean AD: Trauma­
tic aorto-caval fistula associated with horse­
shoe kidney. J Trauma 14: 402, 1974
2. Beall AC, C ooley DA, Morris GC, et al:
Perforation of arteriosclerotic aneurysms
into inferior vena cava. Arch Surg 86: 
809, 1963
3. Baker WH, Sharzer LA, E hrenhaft JL:
Aortocaval fistula as complication of ab­
dominal aortic aneurysms. Surgery 72: 
933, 1972
4. Fairbairn JF, Bernatz PE: Arteriovenous fis­
tulas, in Allen-Barker-Hines Peripheral 
Vascular Diseases, edited by F airbairn  JF, 
Philadelphia, Saunders, 1972, p 318
5. Cortis BS, Jablokow VR, Shah AN, et al:
Spontaneous rupture of abdominal aortic 
aneurysm into inferior vena cava: case re­
port and review of literature. Mt Sinai J 
Med N Y  39: 566, 1972
6. N ennhaus HP, Javid H: Distinct syndrome of
spontaneous abdominal aortocaval fistula. 
Am J Med 44: 464, 1968 
•7. D eBakey ME, Cooley DA, Morris GC, et 
al: Arteriovenous fistula involving abdom­
inal aorta: report of four cases with suc­
cessful repair. Ann Surg 147: 646, 1958 
8. D arling RC, L inton RR: Aneurysm of ab­
dominal aorta with rupture into inferior 
vena cava. Report of two successfully 
treated cases. N Engl J Med 267: 974, 
1962
TOXIC MEGACOLON: RESULTS OF EMERGENCY COLECTOMY*
S. C. PATEL, MB, BS, FRCS[C] and R. M. STONE, MD, FRCS[C]
In order to assess the results of emergency 
colectomy for toxic megacolon in ulcerative coli­
tis, the records of 40 patients treated over a 16- 
year period were reviewed. The diagnosis of 
toxic colon was confirmed by a combination of 
clinical, radiologic, operative and pathologic 
examinations. Steroids were part of the treat­
ment before operation in 36 patients. The sur­
gical procedures included subtotal colectomy in 
37 patients and total proctocolectomy in 3. Fecal 
spillage was recognized in 10 procedures. Two 
patients died postoperatively, but in neither had 
fecal contamination been observed. The findings 
of this review support the use of colectomy as 
the surgical treatment for toxic megacolon.
Dans le but d'evaluer les resultats de la colec- 
tomie d'urgence pour un megacolon toxique lors 
d'une colite ulcereuse, les dossiers de 40 pa­
tients traites sur une periode de 16 ans ont ete 
passes en revue. Le diagnostic de colon toxique 
a ete confirme par une ensemble d'examens 
cliniques, radiologiques, operatoires et patho-
*From the division of general surgery, Toronto 
General Hospital, University of Toronto, Toronto, 
Ont.
Reprint requests to: Dr. R. M. Stone, Division of 
general surgery, Mount Sinai Hospital, 600 Uni­
versity Ave., Toronto, Ont. M5G 1X5.
logiques. Les steroides ont fait partie du traite- 
ment pre-operatoire chez 36 patients. Les inter­
ventions pratiquees comprennent une colecto- 
mie subtotale chez 37 patients et une proctoco- 
lectomie totale dans 3 cas. Un epanchement du 
contenu intestinal a ete constate lors de 10 
interventions. Deux patients sont decedes dans 
la periode postoperatoire mais chez ni I’un ni 
I'autre on n'avait observe de contamination fe- 
cale. Les observations decoulant de cette revue 
soutiennent le recours a la colectomie comme 
le traitement chirurgical du megacolon toxique.
Toxic megacolon may occur in patients with 
nonspecific ulcerative colitis, granulomatous 
colitis, amebic colitis, ischemic colitis, pseu­
domembranous enterocolitis, typhoid fever, 
bacillary dysentery and cholera. It is char­
acterized clinically by dilatation of all or 
part of the colon and severe systemic toxi­
city; radiologically by colonic dilatation, 
loss of h austral pattern and mucosal ulcer­
ation; and pathologically by a transmural 
necrotizing inflammatory process.
Conservative treatment of toxic mega­
colon is associated with high mortality, 
though adequate data are not available. 
Operative treatment by emergency colec-
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tomy is also associated with a high mortality 
(14 to 30)%,! which is attributed to opera­
tive manipulation and disruption of a 
walled-off perforation with resultant fecal 
contamination of the peritoneal cavity. Most 
surgeons and gastroenterologists recommend 
the surgical approach for this serious com­
plication. Recently Turnbull, Hawk and 
Weakley2 suggested that, in the presence of 
a walled-off perforation, colectomy should 
be abandoned in favour of a staged proce­
dure consisting of an initial diverting ileos­
tomy and multiple colostomies. Their report 
led us to review our experience with colec­
tomy and ileostomy.
Patients and Methods
Clinical Material
Between Jan. 1, 1959 and Dec. 31, 1975, 
700 patients with inflammatory bowel dis­
ease were admitted to the Toronto General 
Hospital. In 40 of these patients acute toxic 
dilatation was present on admission or devel­
oped while the patient was in hospital. The 
diagnosis was based on the combination of 
clinical, radiologic, operative and pathologic 
findings; 39 patients had nonspecific ulcera­
tive colitis and 1 had Crohn’s colitis.
There were 23 men and 17 women with 
an age range from 16 to 79 years (mean, 
31 yr). Thirty-two patients were under 40 
years of age. The duration of the disease 
was brief in most patients —  2 years or 
less in 34 patients. Acute toxic dilatation 
occurred during the first attack of ulcera­
tive colitis in 18 patients; 22 had chronic 
ulcerative colitis. The indications for opera­
tion were as follows: free perforation; great 
distension with cecal tenderness; pelvic or 
left-sided peritoneal irritation; deterioration 
in clinical status at any time within 48 
hours; no significant improvement by 48 
hours with vigorous conservative treatment.
Two patients presented with free perfora­
tion and were operated on after appropriate 
resuscitation. Initial management of the re­
maining patients consisted of nasogastric 
suction, intravenous fluid and electrolyte 
therapy, blood replacement, systemic corti­
costeroids, antibiotics and repeated clinical 
and radiologic examination under the guid­
ance of a surgeon and gastroenterologist.
Operative Details
All patients had an emergency operation. 
Thirty-seven patients underwent subtotal 
colectomy and ileostomy and three patients 
had a one-stage proctocolectomy. The rectal 
stump was oversewn in 13 patients and a 
mucous fistula was created in 24.
Fecal contamination of the peritoneal 
cavity was recognized in 10 patients at oper­
ation. In two of these, perforation had oc­
curred before the operation. In eight pa­
tients, operative manipulation and disruption 
of a sealed-off perforation were responsible 
for fecal contamination. This disruption oc­
curred during mobilization of the left colon 
and proximal sigmoid.
The peritoneal cavity was drained in all 
patients with fecal contamination and in 
those in whom the rectal stump was over­
sewn.
Results
In 24 patients (60%) the postoperative 
course was uncomplicated; major complica­
tions developed in 14 (35%) and 2 patients 
(5%) died. Both patients who died had had 
a subtotal colectomy and ileostomy with a 
mucous fistula. Fecal contamination at oper­
ation was not recognized in either case. 
Massive pulmonary aspiration on the 3rd 
postoperative day was the cause of death 
in one 18-year-old patient, and pneumonia 
and progressive respiratory failure caused 
the death of the other 79-year-old patient.
The major complications in the 14 pa­
tients included intra-abdominal abscess (7), 
wound dehiscence (5), massive bleeding 
from the rectal stump (1) and mechanical 
small-bowel obstruction (1).
Management of the rectal stump de­
pended on the extent and severity of the 
primary disease. In 18 patients, subsequent 
rectal excision was necessary. Ileorectal 
anastomosis was done at a later date in one 
patient only.
Discussion
Acute toxic dilatation of the colon con­
stitutes a true surgical emergency. A delay 
in diagnosis is still common. Management 
during the acute stage should be the com-
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bined responsibility of a gastroenterologist 
and a surgeon. Lack of clinical improvement 
within 24 to 48 hours should be considered 
as an absolute indication for surgical inter­
vention. The overall mortality of this con­
dition is still high and only a small unpre­
dictable proportion of the patients recover 
without operation. The importance of early 
operation has been stressed in many recent 
reviews.2'6 In a collective review by Binder, 
Patterson and Glotzer 7 an important deter­
minant of mortality appeared to be perfora­
tion of the colon. Early surgical intervention 
may avoid this complication. The dangers 
of peritoneal contamination during colec­
tomy for fulminant ulcerative colitis are well 
recognized.8' 10
Turnbull, Hawk and Weakley2 recom­
mend a temporizing approach of the “blow­
hole” procedure in situations where a 
walled-off perforation exists. The problem 
here is that it is not always easy to make 
such a diagnosis without first mobilizing the 
colon. The presence of edema extending 
into the lateral gutters does not necessarily 
mean that the colon cannot be removed 
without fecal spillage.
The systemic toxicity exhibited by such 
patients may not decrease until the colon 
is removed. Anesthetic records often dem­
onstrate a slowing of the pulse rate after 
the colonic blood vessels have been ligated.
The “blow-hole” procedure necessitates a 
subsequent operation to remove the colon 
with resultant morbidity and mortality, but 
may have a role in a patient who is mori­
bund with severe peritoneal infection. In
this series the 10 patients who had recog­
nized fecal spillage at operation all survived 
even though a major postoperative complica­
tion occurred in most.
With early surgical intervention, colec­
tomy may be performed with a low mortality 
and is the treatment of choice in toxic 
megacolon. The “blow-hole” procedure 
should be reserved for the occasional patient 
who is moribund.
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SPONTANEOUS PERFORATION OF THE BILE DUCTS IN INFANCY
JARLEY KOO, MB, ChB, FRCS[C],* ADRIAN B. JONES, MD, FRCP[C]t 
and FRANK W. TURNER, MB, ChB, FRCS[C]
The clinical features of spontaneous perforation 
of the bile ducts in infancy differ sufficiently 
from those of other causes of neonatal jaundice 
to allow early preoperative diagnosis as demon­
strated by a report of this condition in a 6-week- 
old infant. Despite its rarity, the clinician should 
be aware of this entity because early recognition 
and surgery will ensure cure in almost all cases. 
The cause of spontaneous perforation of the bile 
ducts is unknown. Trauma, congenital weakness 
and abnormal bile are considered as possible 
etiologic factors.
Le tableau clinique d’une perforation spontanee 
des canaux biliaires chez le nourrisson differe 
suffisamment de ceux des autres causes 
d’ictere du nouveau-ne pour permettre un dia­
gnostic preoperatoire precoce, tel que le de- 
montre un cas signale chez un bebe de 6 
semaines. En depit de sa rarete, le clinicien 
devrait etre conscient de cette affection car 
son diagnostic precoce et la chirurgie en assu- 
rent la guerison dans presque tous les cas. On 
ne connait pas la cause de la perforation des 
canaux biliaires. Les facteurs etiologiques pos­
sibles qui ont ete envisages sont le trauma- 
tisme, une faiblesse congenitale ou une bile 
anormale.
Spontaneous perforation of the bile ducts 
in infants is a rare but serious cause of 
neonatal jaundice. It is usually confused 
with biliary atresia or neonatal hepatitis; 
often diagnosis is delayed or missed alto­
gether. Since Caulfield1 reported the first 
case in the English literature in 1936, only 
isolated reports have appeared,2"3 and to 
date fewer than 60 cases have been reported 
in the world literature. An extensive review 
of the condition was presented by Prevot 
and Babut6 in 1970. In most cases diagnosis 
was made only at operation or autopsy. 
Delayed treatment was common and led to 
unnecessary complications. Conservative 
treatment usually ended in disaster. In this
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paper we report a case of spontaneous per­
foration of the bile ducts in an infant and 
review the literature to draw attention to 
the clinical recognition of this rare condi­
tion and its possible cause.
Case Report
A 6-week-old first-born male infant (birth 
weight, 4.6 kg) was admitted with a history of 
intermittent jaundice since birth, and non­
productive cough and vomiting after feeding 
for a week. The mother’s pregnancy was 
normal throughout and delivery was accom­
plished with forceps at 42 weeks. The infant 
was mildly jaundiced at birth but the jaundice 
subsided gradually and had disappeared at 3 
weeks. The parents were not sure when the 
jaundice returned; they did not notice any 
change in the colour of the stool or urine.
Physical findings revealed a well nourished 
baby with weight and height at the 90th 
percentile. He was moderately jaundiced. The 
abdomen was noticeably distended and there 
was a left inguinal hernia. The liver and 
spleen were not palpable. The hernial sac 
appeared to be filled with fluid, suggesting the 
possibility of ascites. Results of laboratory in­
vestigations are listed in Table I.
TABLE I.—Results of P reoperative Investi­
gations
Investigation Result
Hemoglobin, g/dl 
Leukocyte count,
15
x 10»// 8.7, normal differential
Reticulocytes, % 
Serum:
1.4
Bilirubin, mg/dl 
Glutamic oxaloacetic
6.1; direct, 4.4
transaminase, IU// 
Lactic dehydrogenase,
49
iu  n
Alkaline phosphatase,
294
IU// 346
Protein, g/dl 5.7
Albumin, g/dl 
Amylase, Street and
3.0
Close units/dl < 15
a-antitrypsin, mg/dl >420
a-fetoprotein, [xg/ml <1.0
Prothrombin time, s 
Urine:
Patient, 14; control, 11.4
Bile
Urobilinogen, Ehrlich
2 +
units/dl 0.1
Sweat chloride, mmol// 22
Chest radiograph Normal
Abdominal radiograph Consistent with ascites
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Fig. 1.—Radioactive iodine (131I) rose-bengal Fig. 2.—Extravasation of contrast medium from 
liver scan demonstrates normal uptake at 1V4 distal end of cystic duct, 
hours.
In the interval between admission and opera­
tion the baby’s stool colour varied from pale 
to light brown. A peritoneal tap yielded clear 
yellow fluid, which was sterile. Liver scan 
with 131I rose bengal showed normal up­
take at 1 Vi hours (Fig. 1) and diffuse activity 
throughout the whole abdomen at 24 hours, 
particularly along the paracolic gutters and in 
the pelvis. Spontaneous rupture of the bile 
ducts was considered likely. At operation, 800 
ml of bile-stained fluid was removed. There 
were extensive plastic adhesions between vis­
cera. The liver was normal in size and texture 
but was heavily bile-stained. Contrast medium 
injected through a small polyethylene catheter 
placed in the gallbladder revealed extravasation 
of dye from the junction of the cystic and 
common hepatic ducts (Fig. 2). Further dis­
section confirmed the presence of a small 
perforation (diameter, 1 to 2 mm) in the 
anterior surface of the junction of the cystic 
and the common hepatic ducts. No gallstones 
were seen. Cholecystectomy was performed. 
Choledochography done via a catheter through 
the perforation demonstrated a normal extra- 
hepatic biliary system (Fig. 3). The perforation 
was oversewn with figure-of-eight chromic 
4-0 catgut sutures. The baby made an un­
eventful recovery. Pathologic study of the 
distal end of the cystic duct revealed a well 
demarcated area of necrosis, edema and con­
gestion. In addition bile in the submucosa and 
the subserosa was associated with pronounced 
foreign-body reaction including many foam 
cells. The inflammatory reaction was con­
sistent with an on-going process of 4 to 6 
weeks.
Discussion
The clinical course of spontaneous per­
foration of the bile ducts is usually subacute 
with fluctuating obstructive jaundice. The 
most important clinical feature is abdominal
Fig. 3.—Choledochogram demonstrates normal 
extrahepatic biliary system.
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distension with bile ascites that, if mild, is 
easily missed. The ascites is sometimes 
recognized because of the presence of a 
fluid-filled hernia, either umbilical or in­
guinal. Occasionally in untreated or un­
recognized cases acute symptoms of perito­
nitis develop followed by cardiopulmonary 
collapse and death. In the commoner sub­
acute form, there is typically an elevated 
concentration of serum bilirubin — mostly of 
the direct type —  associated with normal 
liver function, lack of evidence of hemolysis, 
and urine that contains bile and has a low 
urobilinogen value.
The sites of perforation, in order of de­
creasing frequency, are: junction of the 
cystic and common hepatic duct, the com­
mon hepatic duct, the common bile duct, 
the gallbladder, and the junction of the 
cystic duct and the gallbladder.
The cause of spontaneous perforation of 
the bile ducts is unknown. A number of 
factors have been held responsible: trauma,6 
congenital abnormality,7 infection,2- 8 reflux 
of pancreatic secretion,9 obstruction,2 cal­
culi10- 11 and abnormal bile.12- 13 How­
ever, the evidence for these factors was 
mostly circumstantial. A history of trauma 
was seldom elicited in the reported cases. 
It is conceivable that minor trauma during 
birth or neonatal life may exert enough 
traction on the gallbladder through the 
neonate’s weak abdominal wall to avulse 
the cystic duct from the common hepatic 
duct, which is the commonest site of per­
foration. In this connection, the forceps 
delivery used in our case might be relevant. 
Compression of the gallbladder may cause 
a sudden rise in intrabiliary pressure result­
ing in a rupture, perhaps through a con­
genital abnormality such as the locus minoris 
resistentiae,7 or a rare small diverticulum.14
Infection is unlikely to be a primary 
cause of spontaneous perforation of the bile 
ducts because in the cases reported in the 
literature there was rarely any clinical evi­
dence of sepsis. In the few cases in which 
infected bile was recovered, the infection 
probably followed the perforation and was 
secondary to the bile ascites. Similarly reflux 
of pancreatic enzymes, as suggested by the 
presence of fat necrosis around the perfora­
tion, occurred too infrequently to be an
important factor in the etiology of sponta­
neous bile-duct perforation.
Congenital stenosis or stricture of the 
bile ducts has been associated with perfora­
tion, but a direct cause and effect relation­
ship is difficult to substantiate. Most infants 
with congenital biliary stenosis or stricture 
do not have perforation. In the cases in 
which obstruction from congenital narrow­
ing or stricture was found near the perfora­
tion, simple closure of the perforation was 
often successful; this would be unlikely if 
the obstruction had caused the perforation 
in the first place.
Calculi and inspissated bile10' 13 have 
also been implicated in the etiology of bile- 
duct perforation. However, the mere pres­
ence of calculi or thick bile does not prove 
a causal relationship. In the case reports of 
infants with both biliary perforation and 
calculi, the bile ducts were seldom dilated 
and neither acute nor chronic inflammation 
at the site of perforation was mentioned. 
That abnormal bile may be deposited on 
the wall of the bile ducts causing a local 
chemical inflammatory process that weakens 
the site for subsequent perforation cannot 
be refuted. In our case, the microscopic 
picture of localized necrosis, edema, con­
gestion, bile deposition and foreign-body 
inflammation is consistent with such a view. 
However, we believe it more likely that the 
inflammatory reaction was secondary to bile 
leakage from the perforation, which prob­
ably occurred during birth from minor 
trauma.
Conclusions
The diagnosis of spontaneous perforation 
of the bile ducts depends on an awareness 
of the condition, especially if bile ascites is 
present. Confirmatory investigations include 
(a) intravenous cholangiography,15 which 
is often successful despite the elevated 
serum bilirubin concentration as the liver 
function is usually unimpaired in the early 
stage of the disease, and (b) mI rose-bengal 
liver scan with a follow-up reading at 24 
hours or measurement of the radioactive 
tracer in the ascitic fluid obtained by aspira­
tion.16 This will confirm leakage of bile 
into the general abdominal cavity. The 
treatment of spontaneous bile-duct perfora-
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tion is surgery. A variety of procedures 
have been advocated: simple drainage
of the subhepatic space, drainage through 
the perforation, closure of the perforation 
with or without drainage, cholecystectomy 
for perforation of the gallbladder, and some 
form of biliary enteric anastomosis if a 
stricture or stenosis is present. In the case 
reported herein, removal of the gallbladder 
and suture of the perforation were carried 
out with an excellent result.
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EFFECT OF CURRENT PALLIATIVE TREATMENT ON THE 
SURVIVAL OF PATIENTS WITH BREAST CANCER*
J. E. DEVITT, MD, FRCS(Edin), FRCS[C] and D. A. ADVENT1
The length of survival of 302 patients with 
breast cancer, first treated between 1946 and 
1949, who had mostly only contemporary radio­
therapy for metastases, has been reviewed and 
compared with that of 578 patients, first treated 
between 1966 and 1969, who had modern endo­
crine therapy, cancer chemotherapy and radia­
tion therapy. Although patients in the latter 
group demonstrated a significantly increased 
length of survival after the first metastases ap­
peared, these differences were not substantial. 
In spite of impressive regressions in some pa­
tients with metastatic breast cancer after 
modern palliative therapy, the median survival 
after the first appearance of metastases has 
been increased only by about 6 months.
On a etudie la survie de 302 patientes souffrant 
de cancer du sein, dont le traitement a ete ins- 
titue entre 1946 et 1949, et pour qui, a cette 
epoque, la radiotherapie constituait le seul re- 
cours contre les metastases, et on I'a com- 
paree a celle de 678 patientes, dont le traitement 
a commence entre 1966 et 1969 et qui ont eu 
acces aux traitements endocriniens modernes, 
a la chimiotherapie anticancereuse et a la radio­
therapie. Bien que les patients de ce dernier 
groupe aient montre des survies significative- 
ment prolongees apres I'apparition des premie­
res metastases, ces differences n'ont pas ete 
substantielles. En depit des regressions spec- 
taculaires constatees apres un traitement pal- 
liatif moderne chez certaines patientes atteintes 
de cancer du sein en metastase, la survie 
moyenne apres I’apparition des premieres me­
tastases n'a ete prolongee que d'environ 6 
mois.
It is uncertain whether the age-specific 
mortality rates for breast cancer have 
changed in the last 30 years,1' 2 in spite 
of the notable improvement often seen after 
endocrine or chemotherapy in patients with 
metastatic breast cancer. Patients who re­
spond to these forms of systemic therapy
*From the Civic Hospital division, Ottawa clinic, 
Ontario Cancer Treatment & Research Founda­
tion, and the department of surgery, Ottawa Civic 
Hospital, University of Ottawa, Ottawa, Ont.
tMedical student.
Reprint requests to: Dr. J. E. Devitt, Director, 
Continuing medical education, University of 
Ottawa, Ottawa Civic Hospital, 1053 Carling Ave., 
Ottawa, Ont. K1Y 4E9.
often'live longer than those who do not.3 4 
However, this observation may not result 
so much from therapy as from the selection 
of patients with favourable (i.e., responsive) 
disease from among those with aggressive 
disease.
We reviewed the survival of patients with 
metastatic breast cancer who first were 
treated for their primary disease in the pe­
riods 1946 to 1949 and 1966 to 1969. The 
patients in the latter period enjoyed the 
advantages of current endocrine and chemo­
therapy, whereas few, if any, of the patients 
in the former period did. Thus, if current 
palliative treatment lengthens survival, the 
patients in the latter group should have 
survived longer after their first metastases 
appeared. Survival after the first appearance 
of metastases was examined, since it seemed 
likely that the time of recognition of first 
metastases would be similar in the natural 
history of both groups.
Patients and M ethods
The series comprised 302 patients who 
first were treated for breast cancer in the 
period 1946 to 1949 (group 1) and 578 
patients in the period 1966 to 1969 (group 
2). All patients reported to the Civic Hos­
pital division of the Ottawa clinic of the 
Ontario Cancer Treatment & Research 
Foundation. The two groups were followed 
until the end of 1955 and 1975 respectively. 
Location and time of detection of the first 
metastases were noted and survival was cal­
culated from that time for patients who 
underwent definitive breast surgery (277 in 
group 1 and 544 in group 2). Those not 
operated upon had advanced disease that 
was treated by radiation or systemic therapy.
The length of pretreatment history, the 
5-year survival rate, the regional recurrence 
rate and the presenting stage were studied. 
We grouped all patients retrospectively ac­
cording to stage using the following criteria:
Stage 1.— The tumour measured, at 
pathologic examination when possible, 5 cm 
or less in diameter. There was no peau 
d’orange, skin infiltration or ulceration,
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or chest-wall fixation, but skin dimpling or 
tethering, nipple retraction or pectoral 
muscle fixation did not exclude a patient 
from this category. Edema of the arm was 
absent. No supraclavicular lymph nodes 
were palpable. Histologic examination did 
not reveal axillary lymph-node metastases.
Stage 2.—The features of the primary 
lesion were as in stage 1, but histologically 
proven axillary lymph-node metastases were 
present. If those nodes were palpable clin­
ically, they were not fixed to each other or 
to adjacent structures.
Stage 3.—The tumour was larger than
TABLE I.—P atient Aware of T umour Before 
F irst T reatment
Time before 
treatment, 
mo
No. of patients (and %)
Group 1 
(n = 302)
Group 2 
(:n = 578)
55 (18) 206 (35)
1 — 3 75 (25) 150 (25)
3 — 6 62 (21) 73 (13)
6 — 12 40 (13) 21 ( 4)
^ 12 61 (20) 101 (17)
Unknown 9 ( 3) 27 ( 5)
TABLE I I - - P roportion of P atients in  E ach 
Clinical Stage
No. of patients (and %)
Stage
Group 1 Group 2 
(n =  302) (n = 578)
1
2
3
4
149 (49) 267 (46) 
88 (29) 176 (30) 
54 (18) 114 (20) 
11 ( 4 )  21 ( 4)
TABLE III.—Outcome
% of patients (and no.)
Outcome Group 1 Group 2
5-yr survival 53 (159/302) 59 (342/478) 
Regional recurrence 24 ( 66/277) 19 (102/544)
5 cm in its greatest diameter or showed one 
or more of the clinical signs described as 
being absent in the first two stages.
Stage 4.—Distant metastases were known 
to be present.
The chi-square test was used to test statis­
tical significance for the data in Tables I 
to III and the Mann-Whitney test for Table 
IV.
Observations
The interval between patient awareness 
of the tumour and the time patients reported 
for treatment differed in the two groups 
(Table I); whereas in group 1 only 18% 
reported in 1 month or less after noticing 
their tumour, in group 2, 35% had such 
a short history (P <  0.01). Whereas 33% 
of group 1 patients had been aware of their 
mass for 6 or more months, only 21% of 
the group 2 patients had such a history 
(P <  0.01).
There was no change in the proportion 
of patients in the different clinical stages 
(Table II).
There was a trend, not significant, for 
5-year survival rates (P =  0.1) and local 
control rates (P =  0.1) of those who under­
went surgery to improve (Table III).
The length of survival after the first ap­
pearance of metastases was longer for the 
patients in group 2 and for patients whose 
first metastases were lung/pleural, bons or 
regional (Table IV). Though the differences 
in survival time after the various types of 
metastases first appeared were statistically 
significant they were not substantial (only
6 mo).
D iscussion
The patients in group 2 had the advantage 
of modern endocrine therapy and cancer 
chemotherapy and radiation therapy. The
TABLE IV.—M edian Survival After D etection of F irst Metastases
Group 1 Group 2
No. of No. of
Type of metastasis Months patients Months patients P  value
All types................................................. 10 141 14 244 < 0 .01
Lung/pleural..................................................  5 41 13 59 <  0.01
Bone................................................................. 7 45 13 91 <  0.01
Regional.........................................................  13.5 60 18.5 82 < 0.05
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effectiveness of Trasylol in acute 
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mortality and altering the spectrum of the 
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usual measures for the treatment of 
pancreatitis, such as pain relief, 
fasting, gastric suction, etc. “ It 
(Trasylol) can therefore now be 
regarded as a drug which is both 
effective and beneficial in the 
treatment of acute pancreatitis.”  *
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the clotting and the lysis system 
in favour of coagulation. 
Synthetic antifibrinolytics 
are contraindicated if there is 
evidence of active intravascular 
coagulation. Trasylol is indicated 
in all cases of hyperfibrinolysis, 
whether a differential diagnosis 
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patients in group 1 had only radiotherapy 
available for metastatic disease. To assess 
the effect of the modern therapies we studied 
the length of survival after the first meta- 
stases were noted. This starting point was 
used to avoid the increase in survival that 
can result from earlier counting. Indeed a 
trend to improvement in the 5-year survival 
rates was noted but was not significant. In 
group 2 the duration of symptoms was 
shorter though the distribution of presenting 
clinical stages was unchanged. It seemed 
likely that the time in the natural history 
of recognition of first metastases should be 
similar over the 20 years. The symptoms 
of metastases should have been no different 
in both groups.
In spite of the dramatic regressions that 
some patients in group 2 enjoyed, the dif­
ferences in survival time between the two 
groups of patients after appearance of first 
metastases, though significant, were not sul> 
stantial. Presumably the regressions were 
sufficiently few, and of sufficiently short 
duration, that median survival times were 
lengthened by only approximately 6 months. 
This would not alter age-specific mortality 
rates.
C o n c l u s i o n
Current palliative therapy for breast 
cancer, though producing individual impres­
sive regressions, has produced only limited 
increases in median survival after the first 
appearance of metastases. This would ac­
count for the failure of these therapies to 
improve age-specific survival rates.
We thank Dr. R. C. Nair of the department 
of epidemiology and community medicine of the 
University of Ottawa for his kind assistance and 
advice with the statistical analyses.
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AIR EMBOLISM WITH NEUROLOGIC COMPLICATIONS:
A POTENTIAL HAZARD OF CENTRAL VENOUS CATHETERS*
D. M. GRACE, MD, FRCS[C]
In two patients air embolism caused by discon­
nection of subclavian venous catheters resulted 
in cerebral damage. Both patients were receiving 
long-term parenteral nutrition; both were in an 
upright position and were slightly dehydrated 
at the time the embolism occurred. The occur­
rence of air embolism during the insertion of 
central venous or subclavian catheters is well 
known, but the development of this complica­
tion in patients in whom the intravenous line 
becomes disconnected has not been stressed. 
It is important to recognize and treat the con­
dition promptly. Also important in the preven­
tion of this condition is catheterization in pa­
tients who are properly hydrated and who are 
in the Trendelenburg position, and care of the 
catheter thereafter.
Chez deux patientes, une embolie gazeuse causee 
par la disjonction d'un catheter veineux sous-cla- 
vier a entraine des dommages cerebraux. Les 
deux patientes etaient sous nutrition parenterale 
au long cours; les deux etaient en position verti- 
cale et legerement deshydrates au moment oil 
I'embolie est survenue. L'apparition d'une embolie 
gazeuse au moment de I'insertion d'un catheter 
veineux central ou sous-clavier est un fait bien 
connu mais on n'a pas souligne le developpe- 
ment de cette complication avec la disjonction 
d'une tubulure intraveineuse. II est important 
de reconnaitre et de corriger rapidement 
cette complication. II est aussi important de la 
prevenir en procedant au catheterisme chez des 
patients bien hydrates et places dans la posi­
tion de Trendelenburg, et le catheter doit faire 
I'objet d'une attention particuliere par la suite.
In s e r t io n  of catheters into the subclavian 
vein and more centrally is now common on 
surgical wards as a preliminary to parenteral 
nutrition; it has even been recommended as 
a routine procedure before operation.1 
Subclavian or central venous catheterization 
may, however, be complicated by the oc­
currence of air embolism. This may occur 
not only during insertion of the catheter 
but also if the catheter inadvertently be-
*From the department of surgery, University of 
Western Ontario and University Hospital, London, 
Ont.
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comes disconnected during infusion, espe­
cially if the patient is upright. This com­
plication may not be generally recognized.
In this paper we report two cases of cere­
bral damage resulting from air embolism 
associated with long-term parenteral nutri­
tion by subclavian catheterization, and we 
emphasize the diagnosis and prevention of 
the complication.
C ase R e p o r t s
Case 1.—A 52-year-old woman had been 
treated by irradiation of the sacrum for recur­
rent carcinoma of the colon. Subsequently 
severe radiation enteritis and small-bowel ob­
struction developed. Operation for obstruction 
at another centre was followed by a high- 
output jejunal fistula with major skin break­
down. After transfer to our hospital she re­
ceived local wound care and drainage, and 
parenteral nutrition through a subclavian cath­
eter was started. After 3 months of hyper­
alimentation the skin had healed but the fistula 
persisted. Glucosuria resulting from intoler­
ance of the glucose load was treated by re­
striction of glucose and amino acids and 
administration of insulin for several days. One 
morning, while the patient was standing, the 
intravenous line inadvertently became discon­
nected; she immediately collapsed and became 
comatose. Respiration was depressed and she 
was hypotensive. Cardiopulmonary resuscita­
tion was started. She was placed in the left 
lateral decubitus position with the feet elevated 
but remained comatose. One hour later re­
sponse to painful stimuli returned but she had 
a left flaccid hemiparesis. By the next day her 
leg had recovered but the left arm remained 
paralyzed. After several days she regained 
some strength in the left upper arm but weak­
ness of the left hand and loss of finger exten­
sion persisted until her death 8 months later. 
Careful assessment by neurologists revealed no 
other cause for the neurologic change; they 
considered the findings to be consistent with 
air embolism. Hyperalimentation was con­
tinued with the line securely taped in position. 
The small-bowel fistula was later repaired by 
operation.
Case 2.—A 58-year-old woman was treated 
by parenteral nutrition through a subclavian 
catheter because of severe diarrhea and 
weight loss (16 kg) after extensive resection
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of gangrenous small bowel 2 months earlier 
in another hospital. She had a history of vas­
cular disease, and a right femoropopliteal by­
pass graft had been carried out several years 
before.
Radiographs showed about 60 cm of small 
bowel remaining and severe stricture of the 
terminal ileum. After 2 weeks of hyperalimen­
tation the stricture in the ileum was resected 
and the remaining jejunum implanted into the 
ascending colon. Two days later, while she was 
standing, her subclavian line was noted to be dis­
connected. She complained of weakness, then 
quickly collapsed and became comatose. Res­
pirations were depressed. She was immediately 
placed in the Trendelenburg position. Con­
sciousness returned over the next hour but 
her left side was paralyzed and a left Babinski 
sign was noted. Use of her left arm and leg 
returned over the next few hours and 24 hours 
later all neurologic abnormalities had disap­
peared. Her recovery was uncomplicated.
D iscussion
For many years a distinction has been 
made between arterial and venous air em­
bolism. Tiny amounts of arterial air may 
have lethal effects while large amounts of 
venous air may be tolerated.- The causes of 
air embolism are many. Open-heart surgery 
is one cause of arterial air embolism while 
venous air embolism has occurred through 
dural sinuses or major neck veins during 
head and neck operations, especially with 
the patient in the sitting position. Other 
causes of venous air embolism are pneumo­
peritoneum,3 intravenous infusion under 
pressure, perirenal air injection, pneumo­
peritoneum and placenta previa.- Recently 
added to the list is the central venous cath­
eter.4' 8 The volume of air that may pass 
through such catheters in a short time is 
surprisingly great'-’ and may be lethal.4- 7- 8
Though it has been recognized for some 
time4- 7 that air embolism may occur during 
insertion of subclavian catheters it has not 
been emphasized that this complication may 
occur if the line disconnects, especially if 
the patient is upright or is dehydrated,3- 8- 9 
as illustrated in our two patients. Both were 
slightly dehydrated when the air embolism 
occurred. One had glucosuria and the rate 
of infusion of glucose and amino acids was 
reduced for 24 hours. The second had un­
dergone major abdominal surgery several
days before. Both patients were standing 
when the subclavian lines disconnected. In 
the absence of the classical “millwheel” 
murmur one might question whether some 
other event led to collapse and neuro­
logic change. However, disconnection of 
intravenous tubing and subclavian catheter 
in two patients who were lucid and active 
was followed immediately by collapse and 
dense coma. The pattern of subsequent 
neurologic change was the same in each 
patient and it is therefore hard to avoid 
the conclusion of cause and effect.
In any patient with a subclavian or central 
venous catheter sudden cardiovascular col­
lapse should be considered to be caused by 
an air embolism,9 even though pulmonary 
embolism or myocardial infarction are more 
common possibilities. A classical “mill- 
wheel” murmur confirms the diagnosis but 
is often absent.10 The mechanism of death 
seems to be an outflow obstruction of the 
right ventricle.- The left lateral decubitus 
position with the right side up is helpful 
because the outflow tract is then below the 
air and the air lock is apparently relieved. 
The Trendelenburg position improves venous 
return, elevates central venous pressure and 
distends subclavian veins; this makes inser­
tion of a subclavian line easier and helps 
prevent air embolism. In one case reported 
by Ordway9 the Trendelenburg position 
was necessary for days.
Cerebral air embolism may occur with 
small amounts of arterial air, especially if 
the head is higher than the heart, and may 
not be fatal.2 Air may traverse a patent 
foramen ovale when outflow obstruction of 
the right side of the heart leads to very 
high pressures.1" Air may also traverse 
the pulmonary vascular bed by unknown 
means, and air has been observed in cere­
bral vessels during neurosurgical procedures 
on patients in the sitting position.10 In the 
patients described in this paper it is not 
clear if the neurologic change was due di­
rectly to cerebral air embolism or whether 
the hypotension alone, caused by venous 
air embolism, was sufficient.
Prevention
Since treatment of established air em­
bolism is unsatisfactory, prevention must be
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stressed. Routine use of subclavian lines is 
not recommended. Proper hydration when 
possible before insertion of such catheters 
and use of the Trendelenburg position dur­
ing insertion are important. The intravenous 
line and subclavian catheter must be tightly 
connected and taped in position, especially 
if the patient is active. The line may still 
become disconnected under a dressing and 
any wet or bloody stain on the dressing 
should be investigated. A lock connection 
between subclavian catheter and intravenous 
line may be useful although those that we 
have tried so far have not been effective. 
If air embolism does occur the Durant or 
left lateral decubitus position is best; the 
steep Trendelenburg position may also be 
helpful. These may reduce mortality greatly. 
Attempts have been made to aspirate air 
from the heart in cases of established air 
embolism but this method is not reliable. 11 
For cerebral air embolism during cardiac 
surgery a compression chamber and hyper­
baric oxygen have been recommended and 
used with some success.12'1'’
Because of the complications associated 
with central venous catheters and hyper­
tonic glucose we now use Intralipid and 
amino acids by a peripheral route when 
possible.
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BONE LESIONS IN EARLY SYPHILIS
Destructive bone disease is a well known com­
plication of tertiary syphilis. Dismukes and col­
leagues (JAMA 236: 2646, 1976) remind us that 
destructive bone lesions, though rare, may be a 
complication of early syphilis; they report a pa­
tient with secondary syphilis whose findings in­
cluded generalized lymphadenopathy, perianal 
condylomata and a maculopapular rash over the palms, soles and forearms. Laboratory investiga­
tion confirmed the diagnosis of syphilis. The pa­
tient complained of headache, and pain in the 
right shoulder and anterior chest. A swelling was 
noted over the right anterior chest. Osteolytic 
bone lesions were found on radiographic examina­tion; syphilitic osteomyelitis was suspected and 
later confirmed with a tissue diagnosis. Reynolds
and Wasserman (Arch Intern Med 69: 263, 1942) 
reported only 15 cases of bone involvement among 
the 10 000 patients they reported with early in­
fectious syphilis. The skull is most frequently 
affected; headache is the usual clinical symptom  
and is often so severe that acute syphilitic menin­
gitis may be considered in the differential diag­nosis. Bony swellings may be seen. Involvement of 
skeletal structures may precede the mucocutaneous lesions of secondary syphilis or may be the only 
manifestation. Finally, the osteolytic manifestations 
of early syphilis cannot be differentiated radio­
graphically from those due to bacterial or tuber­culous osteomyelitis, multiple myeloma and car­cinomatous metastases.
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ANGIOGRAPHY: AN ESSENTIAL DIAGNOSTIC AID IN 
ASYMPTOMATIC AORTIC ANEURYSM?
ROBERT CYR, MD,* JULES TRUDEL, MD, FRCS[C],t 
ANTOINE G. RABBAT, MD, FRCP[C],t JACQUES TRUDEL, MD, FRCP[C],t 
MICHEL LAFORTUNE, MD, FRCP[C]§ and GUY G. LEMIRE, MD, FRCS[C]1I
Aortography is a highly desirable diagnostic 
procedure for evaluating clinically diagnosed 
abdominal aortic aneurysm. In a retrospective 
study of 83 patients with such aneurysms, rou­
tine angiographic investigation changed the 
course of management in 17. The morbidity as­
sociated with angiography in the investigation 
of abdominal aortic aneurysm has been minimal. 
In this situation angiography provides more in­
formation than ultrasonography and therefore 
should be used routinely.
L'aortographie est une procede de diagnostic 
fort interessant pour revaluation d'un anevrisme 
de I'aorte abdominale diagnostique cliniquement. 
Dans une etude retrospective de 83 patients 
souffrant d'un tel anevrisme, I'examen angio- 
graphique systematique a modifie ie traitement 
chez 17 sujets. La morbidity associee a I’angio- 
graphie employee dans revaluation de I'ane- 
vrisme de I’aorte abdominale a ete minime. 
Dans une telle situation, I'angiographie procure 
plus d'information que I'ultrasonographie et de- 
vrait done etre utilisee de facon systematique.
Aortography is performed reluctantly in 
patients with clinically detected abdominal 
aortic aneurysm (AAA),1 because most 
surgeons believe it is neither safe nor essen­
tial. 2 In this paper we review our experience 
with routine use of aortography to investigate 
asymptomatic AAA in the light of the ad­
vances in noninvasive ultrasound techniques.
Patients and M ethods
Transfemoral or, occasionally, transaxil- 
lary aortography was performed in 83 pa­
tients, hospitalized between Jan. 1, 1967
■ Resident in surgery, University of Montreal, 
Montreal, PQ.
tDepartment of surgery, St-Luc Hospital, Mont­
real.
t Department of medicine, St-Luc Hospital.
§Department of radiology, St-Luc Hospital.
1[ Department of surgery, University Hospital, 
Saskatoon, Sask.
Reprint requests to: Dr. G. G. Lemire, Depart­
ment of surgery, University Hospital, Saskatoon, 
Sask. S7N 0W8.
and Dec. 31, 1975, with a clinical diagnosis 
of AAA. Translumbar puncture was not 
used, and routine ultrasonography was used 
in the last year of the study only. The aver­
age age of the patients was 66.4 years. They 
were divided into two groups depending on 
the results of aortography. Group 1 com­
prised 46 patients (average age, 62.8 yr) 
who underwent operation. Group 2 com­
prised 37 patients (average age, 67.1 yr) 
who were not operated upon.
R esults
Angiography was uncomplicated in 82 of 
the 83 patients; in one patient a distal arte­
rial block caused transient ischemia of the 
great toe. There were no deaths attributable 
to the angiography and no procedure caused 
dissection of the aneurysm. In no patient 
was an operation, scheduled as an elective 
procedure, performed as an emergency 
because of angiography. In one patient the 
catheter was passed through a long mural 
thrombus without any harmful effect (Fig. 
1).
Group 1.—The procedures, in addition
Fig. 1.—Uncomplicated catheter dissection 
through long mural thrombus.
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TABLE I.—Group 2. Reasons for Deferring 
Operation
Reason No. of patients
Secondary to angiographic
fingings................................ 8
Poor run-off.....................  3
Multilevel atherosclerosis. 2
Polyaneurysmal disease . . 2
No aneurysm (C-shaped
aorta)............................  1
Secondary to other causes. . . .  29
Medical contraindications 24
Refusal of treatment........ 2
Cause unknown (chart
unclear)........................  2
Awaiting surgery.............  1
to a bypass operation (bifemoral, 37; bi- 
iliac 9), included renal artery revasculariza­
tion (10 aortorenal bypasses) in seven pa­
tients, release of a left renal artery kink in 
one patient and closure of a renal arterio­
venous fistula, 20 years after nephrectomy, 
in another. Three patients died within 30 
days (mortality, 6.5%); the deaths were due 
to multiorgan failure, disseminated intra­
vascular coagulation and suprarenal intra- 
diaphragmatic aortic rupture.
Group 2 .— In 29 of the 37 patients opera­
tion was postponed for a variety of medical 
and other reasons (Table I). In eight patients 
operation was postponed as a result of aorto- 
graphic findings (Table I); seven patients 
had a vascular contraindication, and one 
was considered from the aortogram to have 
an elongated C-shaped abdominal aorta, 
mistaken for an aneurysm clinically and on 
echography (Fig. 2).
Fig. 2.—Dilated C-shaped aorta mistaken clinic­
ally for abdominal aortic aneurysm.
D iscussion
The morbidity and mortality associated 
with the surgical treatment of AAA is re­
lated to concomitant atheromatous disease 
or ischemia, or both, and is caused by the 
corrective surgical procedure. Angiography 
demonstrates the extent of atheromatous 
disease and, more than any other diagnostic 
aid, has led to advances in the surgical treat­
ment of atherosclerotic disease.3 In experi­
enced hands, angiography is a low-risk 
diagnostic procedure, as is borne out by our 
data. Ultrasonography has added another 
dimension to the investigation of AAA but 
provides only a morphologic picture of the 
lesion —  the outer-inner dimension of the 
aneurysmal formation and its potential or 
existing dissecting tendency.4 It fails to give 
accurate detail of the position of the renal 
arteries in relation to the aneurysm, or of 
the emerging visceral trunks.
The benefits derived from angiography 
in our series are apparent —  the data ob­
tained in the operated cases led to renal 
artery surgery in 9 of 46 operated cases and 
operation was deferred in 8 of 83 cases 
because of the angiographic findings. In 
eight patients angiography called attention 
to critical renal artery stenosis. Aortic re­
construction with concomitant aortorenal 
bypass was done with the primary intent of 
protecting renal parenchyma. The theoret­
ical advantage of preventing malignant 
hypertension in acute renal ischemia consti­
tutes a remote reason.5 Angiography also 
demonstrated a renal arteriovenous aneu­
rysm in one patient. Furthermore, angiogra­
phic findings precluded operation in seven 
patients with vascular complications and 
one with an elongated C-shaped aorta, mis­
taken for an aneurysm. Thus, the manage­
ment of AAA was modified in over 20% 
of the total group (17 of 83) while the 
complication rate due to angiography was 
kept extremely low (1.1%), well worth the 
price considering the crucial information 
obtained.
As Robicsek and colleagues6 pointed out, 
the surgeon can only be thankful that addi­
tional information such as the presence of 
polar renal arteries, aortocaval fistulas, un­
suspected arcades of Riolan, saccular aneu­
rysms and retroperitoneal leaks may be
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uncovered by angiography, thus minimizing 
the element of surprise in the operating 
room. Calm preoperative planning allows 
for adjustments in blood-bank requirements, 
autotransfusion preparation and topical 
hypothermia. Finally, while the operative 
risk of the patient is better evaluated, a more 
informed decision can be made in patients 
in whom operation is deferred.6’ 7 Because 
of its low morbidity, angiography is a safe 
procedure; the information obtained is worth 
the minimal risk incurred.
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TEACHING OF BASIC SCIENCES
JEAN G. COUTURE,
In this paper, important deficiencies in the 
teaching of basic sciences to residents under­
going training in the surgical specialties are 
underlined.
Since the Royal College of Physicians and 
Surgeons of Canada has stipulated that resi­
dents must be successful at an examination in 
basic sciences before being admitted to the final 
examination in certain surgical specialties, it is 
important that program directors plan the 
organization of an adequate program in this 
area.
To achieve this goal, it is suggested that 
closer cooperation is needed between the basic 
sciences and clinical departments of our medical 
schools so that specific objectives may be de­
fined and teaching of basic sciences become 
more consistent with the prerequisites put 
forward by the Royal College.
Dans ce travail, I'auteur souligne d’importantes 
lacunes dans I'enseignement des sciences fonda- 
mentales aux residents inscrits a des program­
mes de formation dans des disciplines chirur- 
gicales.
Etant donne que le College Royal des mede- 
cins et chirurgiens du Canada demande a ces 
etudiants de reussir un examen en sciences 
fondamentales avant de se presenter aux exa- 
mens terminaux dans certaines specialites chi-
* Presented at the meeting of the Canadian Asso­ciation of Clinical Surgeons, Quebec City, PQ, 
Mar. 18, 1975.
Reprint requests to: Dr. J. G. Couture, Depart­ment of surgery, Hopital du Saint-Sacrement, 1050 Chemin Ste-Foy, Quebec, PQ G1S 4L8.
through retroperitoneal approach. J Cardio- vasc Surg (Torino) 9: 224, 19682. Danielson GK, Payne WS: Arteriography andabdominal aortic aneurysm (C). JAM A  209: 1366, 19693. Foster JH: Arteriography: cornerstone ofvascular surgery. Arch Surg 109: 605, 19744. Nusbaum JW, Freimanis AK, ThomfordNR: Echography in diagnosis of abdominal aortic aneurysm. Arch Surg 102: 385, 19715. Darling RC: Peripheral arterial surgery (con­cluded). N  Engl J Med 280: 141, 19696. Robicsek F, D augherty HK, Mullen DC,et al: Value of angiography in diagnosis of unruptured aneurysms of abdominal aorta. Ann Thorac Surg 11: 538, 19717. Brewster DC, Retana A, Waltman AC, etal: Angiography in management of aneu­rysms of abdominal aorta. Its value and safety. N  Engl J Med 292: 822, 1975
IN POSTGRADUATE SURGERY*
MD, FACS, FRCSfC]
rurgicales, il importe que les directeurs des 
programmes universitaires prevoient ('organisa­
tion d’un programme adequat dans ce domaine. 
Pour atteindre cet objectif, I’auteur est d'avis 
qu'une plus grande collaboration devrait exister 
entre les departements de sciences fondamen­
tales et cliniques des facultes de medecine afin 
de definir des objectifs specifiques permettant 
de dispenser un enseignement plus conforme 
aux prerequis proposes par le College Royal.
The teaching of basic sciences at both the 
undergraduate and postgraduate level gives 
rise to some confusion, even among medical 
educators, because of differences in content 
and method.
Thus, in the curricula of some medical 
schools, basic sciences include all aspects of 
human biology; in those of others, the basic 
sciences include biochemistry, physiology 
and cellular biology; and in still other medi­
cal schools, pharmacology, pathology and 
immunology constitute the important com­
ponents of the curriculum in basic sciences. 
Similarly, the term “basic surgery” leads to 
confusion: in some instances it means the 
subject matter (e.g., shock or fluid balance), 
while in others the term refers to the 1- or 
2-year period during which the surgical 
resident is exposed to problems related to 
basic sciences. In general, however, basic 
surgery corresponds to that part of the core 
training related to the basic sciences.
It therefore is worth considering briefly 
the ways in which basic sciences are taught
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to undergraduate and postgraduate students.
D efic ien c ies  in the  T eaching
of  Basic Sciences
In general, during a surgical residency 
knowledge of basic sciences is acquired by 
one of two methods — through permeation 
and through a more formal approach. The 
nature of the permeation method is reflected 
in the words of Hanlon,1 who has defined 
the nature of basic surgery as “a series of 
concepts underlying and permeating the daily 
surgical activities of the candidate”. In his 
opinion, the basic experience may precede, 
follow or accompany exposure to specialty 
activities. Since knowledge acquired by this 
method is related to the capacity of a teacher 
to transmit it to his students, there is doubt 
about the degree of efficiency of such a 
method. With the more formal approach, a 
resident, according to some general sur­
geons and members of surgical disciplines, 
should be temporarily relieved of his 
surgical duties and be assigned for a period 
of time to formal study of basic sciences, 
either in the laboratory or by attending a 
course of lectures covering appropriate sub­
jects.
Although many program directors think 
that residents learn basic sciences through 
permeation or osmosis, neither of these 
methods has proven satisfactory. In fact, 
most residents rely more on their personal 
efforts and studies than on any other sug­
gested method.
The American College of Surgeons and 
the Royal College of Physicians and Sur­
geons of Canada have proposed that basic 
education in surgery for the first 2 years 
be common to all surgical disciplines. After 
this period, definitive training can be ac­
quired for the next 2 or 3 years under the 
responsibility of the directors in the various 
specialties. However, neither the American 
College of Surgeons nor the Royal College 
has defined any specific objectives to help 
program directors in preparing a basic scien­
ce program in the first 2 years. The basic 
surgical program, as proposed by the Royal 
College, consists of a list of subjects that 
residents are expected to study in prepara­
tion for the basic surgical examination after 
2 years of training. However, this program 
is of a general nature and gives the residents
limited help in the preparation for the exami­
nation. This is exemplified by the following 
two topics chosen from the basic surgical 
program of the Royal College:
1. Bleeding, clotting and administration 
of blood
Systems of coagulation and role of 
various factors in intrinsic and ex­
trinsic systems
Common causes of coagulation defects 
Transfusions of blood and blood prod­
ucts
2. Shock 
Definition 
Types
Methods of defining treatment 
Secondary changes in shock 
Treatment.
These two subjects, like all subjects that 
constitute the basic surgical program, are 
not fully defined and cannot be measured 
in a specific way.
At the same time the Royal College re­
quires evidence from the teaching centres 
that a basic surgical program has been or­
ganized and that the teaching of basic 
sciences is satisfactory. This is clearly ex­
pressed in the general guidelines that the 
Royal College sets for itself in evaluating 
specialty training programs. One stated ob­
jective is “to review the scope, objectives 
and content of the training programme in­
cluding the arrangements made for the 
teaching of the basic sciences of the special­
ty in the faculty as well as in the teaching 
hospitals”. Surveys of the teaching institu­
tions by the Royal College and the Cor­
poration Professionnelle des Medecins du 
Quebec has not shown satisfactory evidence 
of arrangements made for the teaching of 
basic sciences. Presently most postgraduate 
surgical programs include a prearranged 
time span of 3 to 24 months in which the 
resident is assigned to various nonclinical 
departments including the animal research 
laboratory, and the surgical pathology de­
partment or the anatomy department, or 
both. Teaching is accomplished by personal 
involvement in the activities of these depart­
ments and in a more formal way through 
attendance at weekly seminars and lectures. 
Learning should be accomplished in part
January 1977 THE CANADIAN JOURNAL OF SURGERY 61
through osmosis in these various milieux 
and in part from the personal program 
developed by the candidate to complement 
his experiences. Clearly the teaching of 
basic sciences is currently superficial and 
not very specific.
There is a need for an integrated basic 
sciences program. Many factors justify the 
organization of such a program (e.g., basic 
medical sciences are presented in an abbre­
viated form; orientation of students is done 
early and many change their minds; to fulfil 
the requirements of the Royal College basic 
surgical examination; to avoid duplication 
such as discussion of the same topics in 
many programs); one of the most important 
factors is the poor integration of basic 
sciences into clinical medicine in most medi­
cal schools. After the first 2 years of under­
graduate training, the medical student is 
given very little training in the basic sciences 
before his 1st year of residency. This lack 
of continuity throws a strain on residents, 
who are faced with a basic surgical examina­
tion after 2 years of training.
It is therefore imperative that staff of 
basic sciences departments of Canadian 
medical schools realize how important is 
their participation in the training program 
not only at the undergraduate level, but also 
at the postgraduate level. The integration 
of scientists into the clinical departments is 
necessary to ensure a “continuum” from the 
1st year of medical school to the last year 
of a residency program.
TABLE I.— R equirements for an Integrated 
Basic Sciences Program
Definition of specific objectives that can be 
measured
Large faculty competent in many diverse sciences
Pedagogic activities that will realize objectives: 
e.g., surgical anatomy, rotations in pathology, 
research laboratory, formal lectures
Part of program to be multidisciplinary
In-training evaluation procedures
A R ecommendation
What then should be done in order to 
make effective a completely integrated basic 
sciences program? The requirements for
such a program are outlined in Table I. 
Specific objectives in basic sciences should 
be defined and should cover all aspects of 
basic sciences knowledge at the under­
graduate and postgraduate levels. This, of 
course, would be more difficult at the post­
graduate level, especially in surgery; 
surgeons are by nature individualists, 
not particularly receptive to the group 
effort required to bring better basic 
science training into surgical post­
graduate programs. An experiment carried 
out at Wayne State University2 proved that 
the best method of achieving this goal is 
to assign the job to a team composed of one 
surgical subspecialist and one specialist in 
medical education. This kind of cooperative 
effort will help program directors define 
specific objectives for basic science educa­
tion in most of the surgical disciplines.
In summary, the following comments can 
be made concerning the teaching of basic 
sciences to residents in general surgery and 
other surgical disciplines:
1. In most medical schools a lack of 
continuity in the teaching of basic sciences 
from the undergraduate to the postgraduate 
level explains in part the inadequate prepara­
tion of residents for a surgical training 
program.
2. Residency programs in surgery con­
tribute little to the teaching of basic sciences 
and, as such, provide limited assistance to 
residents who are expected to pass the 
basic surgical examination of the Royal 
College.
3. While the need for an integrated 
basic sciences program is stressed, it is also 
acknowledged that such a program will re­
quire the definition of specific objectives in 
every surgical discipline and, as a conse­
quence, will bring about a closer coopera­
tion between the basic science and clinical 
departments of Canadian medical institu­
tions.
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PROGNOSTIC USE OF PREOPERATIVE AND IMMEDIATE 
POSTOPERATIVE CARCINOEMBRYONIC ANTIGEN 
DETERMINATIONS IN COLONIC CANCER*
J. H. OH, MD, PhD and L.D. MacLEAN, MD, FRCS[C]
Preoperative and postoperative carcinoembryonic 
antigen (CEA) concentrations are useful in 
predicting the likelihood of recurrence in pa­
tients undergoing curative operations for cancer 
of the colon. The incidence of recurrence was 
studied in three groups of patients followed for 
6 to 18 months after such an operation: 36 
patients (group 1) had preoperative and post­
operative plasma CEA concentrations less than 
2.5 ng/ml; 11 patients (group 2) had a preoper­
ative CEA value above but a postoperative value 
below 2.5 ng/ml; and 11 patients (group 3) had 
preoperative and postoperative concentrations 
greater than 2.5 ng/ml. Cumulative rates of 
recurrence at 6, 12 and 18 months after operation 
were as follows: 0, 3 and 17% in group 1; 0, 9 
and 21% in group 2; and 27, 79 and 79% in group 
3. Statistically there was no difference in the re­
currence rate between groups 1 and 2, but the 
rate was significantly lower in group 2 com­
pared with group 3. The data show that patients 
in whom the immediate postoperative CEA con­
centration returns to normal have a much lower 
incidence of recurrent cancer of the colon than 
patients whose CEA concentration remains 
elevated.
Les concentrations pre- et postoperatoires 
d'antigene carcino-embryonaire (ACE) sont uti­
les pour predire la probabilite de recidive chez 
les patients qui subissent une operation a but 
curatif pour cancer du colon. L’incidence des 
recidives a ete etudiee chez trois groupes de 
patients qui ont ete observes pendant 6 a 18 
mois apres I'operation: 36 patients (groupe 1) 
avaient des concentrations plasmatiques pre- et 
postoperatoires d'ACE de moins de 2.5 ng/ml; 
11 patients (groupe 2) avaient une concentra­
tion preoperatoire superieure mais une valeur 
postoperatoire inferieure a 2.5 ng/ml; 11 pa­
tients (groupe 3) avaient des concentrations 
pre- et postoperatoires superieures a 2.5 ng/ml.
*From the department of surgery, Royal Victoria 
Hospital and McGill University, Montreal, PQ.
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Les taux cumulatifs de recidive, 6, 12 et 18 
mois apres I’operation ont ete comme suit: 
0, 3 et 17% dans le groupe 1; 0, 9 et 21%  dans 
le groupe 2; et 27, 79 et 79% dans le groupe 3. 
Statistiquement, il n’y avait aucune difference 
entre les taux de recidive des groupes 1 et 2, 
mais le taux etait significativement plus bas 
dans le groupe 2 par rapport au groupe 3. Ces 
donnees demontrent que les patients dont les 
concentrations postoperatoires d'ACE retour- 
nent a la normale, ont une incidence beaucoup 
moins elevee de recidive du cancer du colon 
que les patients dont les concentrations d'ACE 
demeurent elevees.
T h e  demonstration of carcinoembryonic an­
tigen (CEA) in cancer of the colon by Gold 
and Freedman1 2 and description of a 
radioimmunoassay for circulating CEA by 
Thomson and associates3 have stimulated 
many clinical studies for diagnostic and 
prognostic purposes. Preoperative CEA 
positivity (concentration, >  2.5 ng/ml) has 
been reported to range from 59 to 97% 
in patients with proven cancer of the 
colon,3’6 and a gross correlation has been 
noted between the CEA concentration and 
the extent of the lesion.5’8 In postoperative 
follow-up, serial CEA determinations have 
proved useful in identifying patients in 
whom recurrence developed.3’10
In this paper we assess the prognostic 
value of preoperative and immediate (1 to 
2 wk) postoperative CEA concentrations in 
relation to cancer recurrence following cura­
tive surgery.
Patients and Methods
In 58 patients with resectable colonic can­
cer, plasma CEA concentrations were de­
termined before and 1 to 2 weeks after 
operation. The patients were divided into 
three groups depending on their preoperative 
and immediate postoperative CEA concen­
trations (without reference to the pathologic 
stage of the disease) as follows: group 1 (36 
patients), both preoperative and postopera­
tive CEA concentrations of less than 2.5 
ng/ml; group 2 (11 patients), CEA value
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TABLE I —Incidence of Cancer Recurrence
Group
Follow-up,
mo
N o. o f patients 
at risk
No. o f 
recurrences
Cumulative  
recurrence, %
1 .................................. ............ 0 — 6 36 0 0
6 — 12 35 1 3
12 — 18 28 4 17
2 .................................. ............ 0 — 6 11 0 0
6 — 12 11 1 9
12 — 18 8 1 21
3 .................................. ..........  0 — 6 11 3 27
6 — 12 7 5 79
12 — 18 1 0 79
Fig. 1—Recurrence rates of colonic cancer after 
curative surgery (group 1 preoperative and post­
operative CEA values <  2.5 ng/ml; group 2 pre­
operative value >  2.5 ng/ml, postoperative value 
<  2.5 ng/ml; group 3 preoperative and post­
operative values >  2.5 ng/ml.)
greater than 2.5 ng/ml preoperatively and 
less than 2.5 ng/ml postoperatively; and 
group 3 (11 patients), preoperative and post­
operative CEA values greater than 2.5 ng/ml. 
Follow-up in each patient was from 6 to 18 
months postoperatively; cancer recurrence 
was assessed by periodic clinical assessment, 
operative and autopsy findings, as well as 
CEA determinations.
Plasma CEA concentration was measured 
by the radioimmunoassay technique of Elan- 
sen and colleagues.11
The rates of recurrent cancer of the colon 
were calculated at 6, 12 and 18 months 
after operation by life-table analysis.12 Stat­
istical comparison of the recurrence rates 
was carried out by the chi-square technique. 
We also compared the preoperative CEA 
values of groups 2 and 3.
R esu lts
Recurrence Rates
Cumulative rates of cancer recurrence for 
each group at 6, 12 and 18 months post­
operatively are set forth in Table I and 
Fig. 1.
Comparison of recurrence rate in groups
1 and 2.—Kates of recurrence were com­
pared first between groups 1 and 2, both 
having a postoperative CEA concentration 
less than 2.5 ng/ml. Expected frequencies 
of recurrence were calculated from the num­
bers related to the two groups in Table I. 
The overall comparison is shown in Table 
II. Chi-square analysis revealed no signifi­
cant difference in cancer recurrence between 
the two groups (P >  0.70).
Comparison of recurrence rate in groups
2 and 3.—Rate of cancer recurrence in 
group 2 was then compared with that of 
group 3, since the postoperative CEA con­
centrations remained elevated in group 3 
only. Expected frequencies of recurrence 
were similarly calculated from the numbers 
related to the two groups in Table I, and 
the overall comparison is shown in Table 
II. Chi-square analysis revealed a significant 
difference (P <  0.025) in the recurrence 
rate between the two groups, the rate being 
greater in group 3.
Comparison of Preoperative CEA in
Groups 2 and 3
Individual preoperative and postoperative 
CEA values in groups 2 and 3 are shown 
in Fig. 2. In group 2 the preoperative CEA 
values ranged from 3.2 to 11.6 ng/ml (mean 
and SD, 5.3 ±  2.8); in group 3 the levels
PL
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M
A 
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A 
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m
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TABLE II.—Comparison of Cancer Recurrence R ates
Group
Follow-up, 
mo
1  V . 2* 2 v. Jt
Observed Expected Observed Expected Observed Expected Observed Expected
0 — 6 0 0 0 0 0 1.50 3 1.50
6 — 12 1 1.53 1 0.47 1 3.67 5 2.33
12 — 18 4 3.88 1 1.12 1 0.83 0 0.17
*X2 = 0.795; P (2 degrees of freedom) > 0.70. 
tx2 = 8.210; P (2 degrees of freedom) < 0.025.
GROUP 2 GROUP 3
Fig. 2.—Preoperative and postoperative plasma 
CEA concentrations in groups 2 and 3. Vertical 
bars indicate mean ±  SE.
ranged from 4.6 to 25.0 ng/ml (mean and 
SD, 12.7 ±  7.0). The difference in the pre- 
operative CEA values between the two 
groups was statistically significant (P <  
0.025).
D iscussion
Since the development of a radioimmuno­
assay for plasma CEA, the test has been 
widely used for the diagnosis and postopera­
tive follow-up of patients with colonic can­
cer. The test is of limited diagnostic value 
inasmuch as varying proportions of patients 
with proven cancer of the colon have a nor­
mal plasma CEA concentration (<  2.5 
ng/ml),3' 6 but the test has proved valuable 
in reflecting the extent of disease.3'8 These
findings led us to examine the prognostic 
use of initial (pre- and postoperative) CEA 
values in the subsequent follow-up of pa­
tients without reference to pathologic stages 
of disease. We emphasized the immediate 
postoperative CEA values in relation to 
cancer recurrence.
The data show that patients with abnor­
mal preoperative CEA concentrations but 
normal postoperative concentrations (group 
2) had a rate of cancer recurrence similar 
to group 1 patients with normal values pre- 
and postoperatively. However, the recur­
rence rate in group 2 patients was signifi­
cantly lower than of group 3 patients, whose 
CEA values remained abnormal postoper­
atively, implying that surgery was more 
effective in group 2 than in group 3. The 
average preoperative CEA concentration was 
significantly higher in group 3 than in group 
2, probably because of the extent of the 
disease in group 3.
We conclude that preoperative and im­
mediate postoperative CEA concentrations 
are valuable in predicting the recurrence of 
colonic cancer after clinically curative sur­
gery. Systemic antitumour therapy may be 
considered on the basis of the postoperative 
CEA value.
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CANADIAN SURGERY DURING THE FRENCH REGIME, 1608 TO 1763*
R. A. MACBETH, MD, FRCS[C]t
The history of medicine in Canada, from the 
establishment of Quebec by Champlain in 1608 
to the ceding of Canada to the British by the 
French at the Treaty of Paris in 1763, represents 
one of the most colourful periods in the history 
of Canadian surgery. Physicians were notable by 
their absence and what medicine was available 
in La Nouvelle France was provided almost ex­
clusively by surgeons, or apothecaries, or in­
dividuals who posed as such. Sketches from the 
lives of five surgeons (Bonnerme, Giffard, Gou- 
pil, Bouchard and Sarrazin), an apothecary (He­
bert) and a physician; (Gaultier), are presented 
to highlight various facets of medical care and 
the leadership role played by medical practi­
tioners in the development of Canada during 
that period. In addition the study reveals the 
conflict between the philosophical approach of 
the physician and the pragmatic approach of 
the surgeon in 17th century France.
L'histoire de la medecine au Canada depuis 
I'etablissement de Quebec par Champlain en 
1608 jusqu'au Traite de Paris en 1763, par lequel 
le Canada a ete cede des Francais aux Anglais, 
represente une des epoques les plus frappantes 
dans l’histoire de la chirurgie canadienne. Les 
medecins brillaient par leur absence et la me­
decine qui a ete disponible a la Nouvelle France 
etait fournie par des chirurgiens, ou des apothi- 
caires, ou des individus qui se passaient pour 
tel. Des croquis des vies de cinq chirurgiens 
(Bonnerme, Giffard, Goupil, Bouchard et Sarra­
zin), un apothicaire (Hebert) et un medecin 
(Gaultier) sont presentes pour mettre en vedette 
des facettes diverses des soins medicaux et le 
role important qui a ete joue par des praticiens 
medicaux dans le developpement du Canada 
pendant cette epoque. En plus, cette etude fait 
connaitre la lutte entre I'approche philosophique 
des medecins et contre la mentalite pragmati- 
que des chirurgiens en France au XVIIeme sie- 
cle.
The history of Canada, and with it the his­
tory of medicine and surgery in this country,
* Presented in part at the XXV International Con­
gress for the History of Medicine, Quebec, PQ, 
Aug. 21-28, 1976.
tFrom the departments of surgery, Dalhousie 
University, Halifax, NS and the Saint John 
General Hospital, Saint John, NB.
Reprint requests to: Dr. R. A. Macbeth, 310 
Saint John General Hospital, Saint John, NB 
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can conveniently be divided into four broad 
periods, each approximately a century in 
duration. The first period may be referred 
to as the Age of Discovery. It extended from 
1497, when Giovanni Caboto (John Cabot), 
under letters patent from Henry VII of 
England, first explored the Atlantic sea­
board of Canada, through the period repre­
sented by the three remarkable voyages of 
discovery of Jacques Cartier to the Gulf of 
St. Lawrence and St. Lawrence River under 
the patronage of Francois I of France, to 
1608, when the age of colonization began. 
Medically, this period involves the study of 
the tantalizing but fragmentary evidence 
that supports the contention that medical 
personnel were included in the ship’s com­
pany during those early voyages and the 
conditions with which they were obliged to 
contend.
The second period is precise in its limits 
and incontestable in its documentation. It 
is commonly referred to as the Age of Settle­
ment or as the Period of the French .Regime. 
It began on July 3, 1608, when Samuel de 
Champlain established his Habitation at 
Quebec, and extended through a century 
and a half of hardship and conflict to 1763 
when, at the First Treaty of Paris, Canada 
was ceded, for the last time, to Britain.
The third period is delimited more by 
what precedes and what follows it than by 
its own distinctive features. The term, the 
Age of Transition, or perhaps the Period 
of the Early British Regime, appears a rea­
sonable designation for the century extend­
ing from 1763 to 1867. Medically, this 
period was highlighted by the initiation of 
“modern” medical education in this country 
when, in 1829, the Montreal Medical Insti­
tute of 1824 (an outgrowth of the Montreal 
General Hospital, which was built in 1822) 
was engrafted on McGill University (which 
had been founded in 1819) and Canada’s 
first medical school was born.
The fourth, or modern period, is ap­
propriately designated as the Age of Con­
federation and extends from 1867, when 
confederation of the Canadian provinces 
was achieved, up until the present.
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Although this presentation contributes no 
new or original material concerning Cana­
dian surgery during the French regime, the 
history of the French regime is unknown to 
most anglophone Canadians. Much of the 
background material is published only in 
French, and often in ancient French, and a 
large share of the source material, both 
French and English, is held in special library 
collections and is not available on a loan 
basis.
Background
At the outset it is important to establish 
certain facts regarding the organization of 
the medical profession in France and cer­
tain features that characterized the physi­
cian, the surgeon and the apothecary of 
that era. This is not to suggest, as Nadeau1 
is careful to point out, that the organization 
of the medical services in New France simu­
lated those in the mother country. Every­
thing about life in the embryo colony de­
manded a new approach to the provision of 
medical care, as it did to virtually every 
other type of service. However, the men who 
fashioned the medical structure of New 
France were part of a medical hierarchy 
that had taken centuries to develop and 
from whose basic tenets they were unable 
totally to divorce themselves.
The Surgeon
Gelfand2 has stated that the dichotomy 
between physician and surgeon had its 
origins in the Middle Ages and that by the 
dawning of the 17th century in France it 
had reached a point where the physician, a 
member of the Faculty of Medicine at Paris 
or one of the provincial university cities, 
was identified as a scholar and theoretician 
while the prototype of the lowly surgeon 
was an uneducated, apprentice-trained 
craftsman. Earlier, rare exceptions existed 
to this model of the surgeon in that a rela­
tively ksmall group of “educated” surgeons 
maintained a precarious existence as mem­
bers of the College of St. Come.*
*Come or Cosme is the French equivalent of 
Cosmas, who, with his brother Damian, suffered 
martyrdom as a Christian under the Roman em­
peror Diocletian in about 295 AD. The brothers 
are usually considered to be the first Christian 
physicians. Both were canonized and Saint Cosmas 
is commonly considered the patron saint of sur­
geons.
In 1656 the College of St. Come merged 
with the guild of barbers and in 1660 the 
Parliament of Paris declared that hence­
forth all surgeons were officially barber- 
surgeons and, as such, subordinate to the 
Faculty of Medicine. It took 83 years, an 
operation for anal fistula on Louis XIV, 
and the combined persuasion of a distin­
guished succession of “first surgeons to the 
king” (including Charles Frangois Felix, 
Georges Mareschal and Frangois de la Pey­
ronie) before surgery emerged as a re­
spectable and independent profession. The 
milestones along the route included the 
establishment of five endowed teaching 
chairs in surgery by Louis XV at St. Come 
in 1724, the achievement of the right of 
censorship of surgical publications by sur­
geons in 1730 and the formation of the 
prestigious Academie Royale de Chirurgie 
in 1731. All these functions had previously 
been vested in the powerful Faculty of 
Medicine, to which all surgeons were sub­
servient. The final triumph for the surgeons 
came in 1743 when Louis XV terminated 
the union of surgeons and barbers, defined 
the exclusive boundaries of the areas of 
activity for each group, and finally made 
surgery an art savant and a “true science” 
by requiring that prospective surgeons be 
taught Latin and philosophy and acquire a 
master of arts degree from the university 
prior to becoming a master surgeon.2
Although the emancipation of surgery in 
France corresponds with the final phases 
of the French regime in Canada, throughout 
the period under discussion the surgeon 
was classed as a labourer, not a professional. 
Nadeau1 has described the surgeons’ status 
well, although his words may suffer in 
translation.
He was a man of the working class, he did not 
practise a profession but rather a trade. He was 
therefore identified as a member of the working 
class at the same social level as, for example, 
the armourers, carpenters, and shoemakers . . ! 
The Physician was able to become a baron, count, 
or marquis since his profession was the product 
of the activity of the mind and not of the work 
of the hands, but it was forbidden that the surgeon 
aspire to nobility. His working class status ex­
cluded him even from the bourgeoisie. Surgeons 
were the servants of the physicians who scorned 
them and demanded respect and obedience from 
them, as well as a subordination that the physician 
almost came to believe was derived from God.
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Surgeons in Canada under the French 
regime were referred to by the use of various 
qualifying words or phrases, a practice that 
has added immeasurably to the problems of 
the historian. Frequently, too, the same in­
dividual has been identified differently by 
different authors, or even the same author 
at different times. (Roland,3 briefly, and 
Nadeau,1 extensively, have discussed this 
point and should be consulted for further 
clarification with respect to it.) Although it 
is clearly an oversimplification, individuals 
who treat disease actively by manipulation 
or operation will all be referred to in this 
paper simply as surgeons. It is appreciated 
that most, if qualified at all, were doubtless 
barber—surgeons. A few may have been 
master surgeons. However, it is difficult to 
be precise on this point.
The Physician
What, then, of the French physician of 
this period? Did he justify this exalted posi­
tion and was his opinion of himself shared 
by his contemporary nonmedical colleagues? 
Again, Nadeau’s1 impressive description is 
well worth translation.
The doctor of medicine disdained menial tasks 
and, in assuming his noble role, shut himself off 
from the world around him. He taught anatomy 
but was careful not to touch the cadaver. While 
he spoke, seated in his elevated chair, a prosector, 
most often a surgeon, handled the scalpel. The 
physician considered that he demeaned himself 
by carrying out a surgical procedure. If he had 
been a surgeon before receiving “le bonnet”* he 
had to promise to never again soil his hands by 
engaging in that trade. Moreover, in Paris, he 
was required to renounce his membership in the 
surgeon’s guild by means of an oath taken before 
a notary in order to preserve the dignity of the 
medical corporation pure and intact . . . While 
the surgeons improved their position through 
perfecting themselves in their art, the physicians 
refused to budge. Full of their own dignity, 
speaking Latin, proclaiming the preeminence of 
their profession, they extended their haughty 
despotism over all that which concerned the art 
of healing and obstinately maintained a fanatical 
respect for tradition and looked upon all progress 
with horror.
Physicians were the object of ridicule in 
the theatre and the literature of their day. 
Delaunay4 quoted a popular jingle of that
*The academic cap (le bonnet) is used figurative­
ly as the badge that identifies the physician as 
holding a doctorate of medicine.
period of which, fortunately, an English 
translation is available.5 It is said to be 
anonymous and goes as follows:
First of the pedant you borrow the air,
And with a long wig cover up all of your hair: 
Then trick out your habit with fur and with satin, 
And constantly babble in Greek and in Latin.
In this combination, you’ll readily see,
You’ve most all that’s neded to be an M.D.
When one appreciates the grandeur of 
the physician of the Paris Faculty of Medi­
cine in full dress one can well understand 
his disinclination to soil his hands, for he 
was indeed an imposing spectacle. Delau­
nay4 has written that he wore a purple 
cassock and over that a scarlet cloak with 
an ermine hood. At his neck he wore the 
usual bands and on his head the square cap 
(le bonnet carre) with a crimson tassel. He 
also describes the physician’s costume at 
Reims, Montpellier and Poitiers and one 
forms the impression that they must surely 
be in competition to achieve the most strik­
ing combination of form and colour. Fig. 1 
illustrates a Dutch, rather than a French 
physician, of the 17th century examining the 
pulse of his patient, as portrayed by Jan
Fig. 1.—Physician examining pulse of patient. 
Painting by Jan Steen (1626-79) in the Rijksmu- 
seum, Amsterdam. (Reproduced from H uard P, 
G rmek MD: La Chirurgie Moderne. Ses Debuts en 
Occident: XV1\ X V l l ‘\  X V IIt Siecles, Paris, Da- 
costa, 1968.)
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Steen. It is more striking in colour but 
makes its point even in black and white.
The Apothecary
The physician of 17th-century France 
presents such a ridiculous picture that one 
has difficulty resisting the temptation to 
spend more time describing his foibles than 
is justified by his medical importance, at 
least in the New World. The apothecary, on 
the other hand, was medically a far more 
useful citizen. Like the surgeon, he was 
classed as a tradesman and was equally the 
object of the scorn of the physician. Some 
insight into his training is given by Drolet6 
in his brief biography of Florent Bonnemere, 
a Jesuit lay brother and apothecary who 
served in Canada under the French regime. 
He states:
In the 17th century [the apothecary’s art in France 
was] controlled by a guild just as surgery was. 
The apothecaries had their own college, and after 
an apprenticeship of seven years they had to sub­
mit a master’s thesis and a pharmaceutical “mas­
terpiece”. Their principal function was that of 
preparing medicines as prescribed by doctors; 
they were obliged to deliver them to the patient’s 
home and to observe their effect.
However, it is clear that in New France 
the apothecaries functioned as independent 
practitioners, in no way dependent on the 
prescription of the physician. There were, 
in fact, virtually no physicians available to 
write prescriptions.
Again we can do no better than refer to 
Nadeau1 in attempting to determine the 
relative importance of these widely divergent 
practitioners of the healing art. He advises 
us that:
during the entire French Regime, only two physi­
cians practised their art throughout the breadth 
of the colony —  three if one counts Bonamour 
who made haste to return to France shortly after 
his arrival. In addition, of these two physicians 
Sarrazin, the best known, had been a surgeon 
and remained one until the end of his life in spite 
of the prejudice associated with this craft. The 
history of medicine in this country is then, above 
all, a history of surgery and of surgeons.
Although not included in this quotation 
Nadeau’s view would be consistent with the 
inclusion of the apothecary as worthy of 
a place in the history of medicine of this 
epoch in New France. Boissonnault7 ex­
pressed the same sentiments succinctly: he 
observed that during almost 150 years
there had been no physicians in Canada and 
quoted the scoffers as noting that no one 
was apparently the worse off as a result.
S e v e n  P r a c t it io n e r s  o f  t h e
F r e n c h  R eg im e
This, then, is the background of our over­
view of the activities, medical and other­
wise, of surgeons and apothecaries in this 
country commencing with that memorable 
day, July 3, 1608, when Champlain estab­
lished, at Quebec, the first Canadian colony 
that was to survive. No authentic portrait of 
Champlain exists but he was a prolific re­
corder of the events that he witnessed and 
the geographic features and the flora of the 
regions he visited. He has left us the draw­
ing of his Habitation at Quebec, reproduced 
in Fig. 2.
Fig. 2.—Champlain’s Habitation at Quebec. 
(Reproduced from Champlain S d e : Oeuvres de 
Champlain, vol 2 (1608-1613). Reprinted, trans­
lated and annotated by Biggar HP (editor), 
Toronto, Champlain Society Publications, new 
series, 1925.)
The task of synthesis is not easy, for the 
period under review is lengthy and includes 
between 150 and 200 surgeons and apo­
thecaries. The seven individuals chosen for 
inclusion have been selected to emphasize 
a particular point and are not necessarily 
representative of the entire group. As it 
turns out, all seven appear to have been 
accepted as highly competent and reputable 
practitioners of their art. This alone would 
perhaps make them unique. Leblond8 re­
minds us that:
the laws at the time forbade a ship to leave 
France on a voyage to the colonies without a
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surgeon or an assistant surgeon on its staff. This 
man often remained in the colony and estab­
lished a practice, something he could not have 
done in France. These newcomers were far from 
being fully qualified. Many had no training what­
soever.
Maude Abbott9 would encourage us to 
approach the 17th century as two distinct 
and unique half-centuries. She refers us to 
Ornstein’s thesis that the first half-century 
was characterized by individual experiment 
and discovery and the formulation of the 
elemental laws governing science, while the 
second half was characterized as a period 
of correlation when scientists joined to­
gether in groups to form the great scientific 
societies of the day for the discussion, con­
solidation and diffusion of this new knowl­
edge. Abbott then identified a parallel in 
the pattern of activity of medical personnel 
in Canada of the same era. The foundations 
of this country were laid in the first half 
of the 17th century by a few dedicated in­
dividuals and individualists, among them 
surgeons and apothecaries. While these 
same persons served the modest colony 
medically, often with great devotion and 
distinction, their main claim to a place in 
the annals of history was their nonmedical 
activities. In putting this period in perspec­
tive it should be remembered that it was 
indeed a modest band that clung tenacious­
ly to life in this harsh land. Twenty-five 
souls passed that first winter in Quebec 
with Champlain of whom 15 died before 
spring. Forty years later in 1648, at mid­
century, the entire population of New 
France was only 241 persons.9
New France in the second half of the 
17th century and early 18th century was 
completely different; in 1663 New France 
became a royal colony and as a result of 
the stimulus this gave to immigration, its 
population exceeded 15 000 by 1698.9 This 
made possible a medical organization capa­
ble of sustaining the type of surgeon- 
scientist who represented the colonial arm 
of those great scientific societies that charac­
terized the mother country of that era. Two 
among this small but illustrious band will 
be chosen to exemplify this aspect of colonial 
medical life. Since there were an additional 
94 documented medical practitioners in the 
colony in the latter half of the 17th century,
our sample is in no sense representative of 
the total colonial medical service of that 
day, but it does highlight the reawakening 
of scientific thought, even in a remote co­
lonial setting.
Bonnerme
Among the hardy band that landed at 
Quebec with Champlain in 1608 was a 
surgeon, identified only as Bonnerme. He 
might have gone completely unidentified 
were it not for his implication, in error, in 
a plot on Champlain’s life shortly after their 
arrival. Biggar10 has translated Champlain’s 
own account of the incident in these words: 
“The same day I had six pairs of handcuffs 
made for the authors of the plot, one for 
our surgeon, named Bonnerme, one for an­
other man named La Taille, whom the four 
conspirators had accused, which charge how­
ever turned out to be false and this was the 
justification for giving them their liberty.” 
Justice in those days was carried out with 
speed and vigour. Jean Duval, the instigator 
of the plot, was hung and his head displayed 
on a pike from the highest roof of the 
Habitation, and his three accomplices spent 
the remainder of their lives in the gal­
leys.11- 12 Although Bonnerme was totally 
exonerated his life was not long spared, as 
Champlain10 records:
The scurvy began very late, that is in February, 
and lasted until the middle of April. Eighteen 
were struck down with it and of these ten died; 
and five others died of dysentery. I had some 
of them opened to see if they were affected like 
those I had seen in the other settlements. The 
same conditions were found. Some time after 
our surgeon died. All this gave us much trouble, 
on account of the difficulty we had in nursing 
the sick.
The first harsh winter in the New World 
had claimed its first surgeon. He would not 
be the last.
Louis Hebert
More fortunate was the apothecary Louis 
Hebert.9- 13’ 14 He arrived at Quebec with 
his family in 1617 at age 40 and in the 10 
years of life remaining to him established 
the agricultural base for the colony which 
was to assure its survival. As the first set­
tler he is remembered as Le Pere de la 
Nouvelle-Franee, and the artist C. W. 
Jefferys presents him in his traditional role
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Fig. 3.—Louis Hebert (courtesy of the Public 
Archives of Canada).
as an apothecary (Fig. 3). Hebert was not 
a stranger to the New World. He spent the 
winter of 1604-5 on lie St. Croix and that 
of 1606-7 at Port Royal in Acadia with 
Champlain and returned to the latter site, 
accompanied by his wife, with the little 
band that Poutrincourt hoped to establish 
there in 1610. They might well have suc­
ceeded had Port Royal not been destroyed 
by the English under Argali, in 1613, and 
the colonists forced to return to France.
There is ample evidence from contem­
porary records,9’ 13 referring both to He­
bert’s sojourn in Acadia and his later life 
in Quebec, to confirm that he practised his 
apothecary’s craft with skill. Moreover, he 
must have been a kindly man for he “en­
joyed the confidence also of the Indians, 
whom he, in contrast to many of his con­
temporaries, considered as intelligent hu­
man beings lacking only in education. Many 
instances bear witness to their respect and 
affection for him.”13 He was equally re­
spected by the other colonists and it is re­
corded of the Heberts and their daughter
and son-in-law that they “had the respect 
and affection of the entire community, and 
their homes were long a centre of hospitali­
ty and of refuge from the common dan­
gers”.9 One would have thought that his 
life would have been a tranquil one, com­
plicated only by the physical hardships of 
the country itself. However, this was not 
the case. The very attribute that made him 
pre-eminent among those early settlers, his 
love of the land and his ability to wrest a 
bountiful harvest from it by dint of knowl­
edge and hard labour, brought him into 
conflict with the powerful trading companies 
who could see no further than the imme­
diate and rich returns available from ex­
ploiting the fur trade. They looked upon 
colonization as a threat and did everything 
in their power to oppose and obstruct his 
attempts at farming and the disposal of his 
produce. However, right triumphed and He­
bert’s industry, courage and integrity event­
ually won the day and secured the colony.
Robert Giffard
If Hebert was the pioneer colonist- 
apothecary, the surgeon Robert Giffard9- 15 
achieved the distinction of becoming the 
first colonizing seigneur. He first came to 
Quebec in 1627, the year of Hebert’s death, 
as surgeon to a vessel involved in the fur 
trade. He liked what he saw that summer 
in the wooded country around Beauport, 
built himself a log cabin for future use, and 
determined to return. His attempt to return 
the following year proved disastrous. War 
had broken out between France and Eng­
land and the ship on which he sailed was 
intercepted by an English flotilla in the St. 
Lawrence with the loss of all of the equip­
ment he had brought with him to start a 
colony. In recognition of his loss and as a 
means of assisting themselves in meeting 
their commitments with respect to immigra­
tion, the Compagnie de la Nouvelle France 
granted Giffard the first seigneury in Can­
ada, that at Beauport, in 1634. “This was 
the first time that a title of nobility was 
conferred upon a Canadian settler, and 
nobly did Giffard fulfil his obligations, for 
he immediately took the important step of 
arranging to bring out, with his wife and 
five children, a number of artisans and 
labourers from Perche in Normandy.”9 At
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the census of 1666 the Seigneury of Beau- 
port consisted of at least 29 households and 
184 persons.15 Giffard certainly more than 
fulfilled his obligation as a colonizer.
Nor should Robert Giffard be discounted 
as a surgeon. He was the first to bear the 
title, King’s Physician, in the New World. 
The fact that in the colony a surgeon, or 
even an apothecary if need be, could hold 
the title of (King’s) Physician was an ano­
maly that could not have occurred in France, 
and it is a practice that has apparently led 
to confusion by historians. Nadeau1 goes 
to great pains to clarify this situation. By 
royal brevet a surgeon could be given the 
title and the administrative rights and 
privileges of King’s Physician in Canada. 
In essence this made him the senior medical 
official in the colony. However, royal author­
ity could not create a physician in the sense 
of an individual holding the doctorate of 
medicine (le bonnet). The term is therefore 
an unfortunate one and much confusion 
could have been avoided had some other 
title been used to identify this prestigious 
administrative position.
One of the functions of the King’s Physi­
cian was that he was physician to the king’s 
hospital: that is, l’Hotel-Dieu de Quebec. 
Giffard was appointed to both offices in 
1640. L’Hotel-Dieu de Quebec was Can­
ada’s first hospital and is the fifth oldest 
hospital in the British Commonwealth.10 
The amazing story of its origin in 1639 un­
der the patronage of the Duchesse d’Aiguil- 
lon, niece of Cardinal Richelieu, is briefly 
outlined by Abbott9 and in the biography 
of its first superior, Sister Saint-Ignace, in 
the “Dictionary of Canadian Biography”.17 
It is completely recorded in French in Cas- 
grain’s book18 but the emphasis here is a 
religious rather than a medical one.
While many references indicate Giffard’s 
humanity and value to the colony as a sur­
geon, he will be remembered primarily as 
Canada’s first colonizing seigneur. His 
manor house was completed in 1636 and 
forms the focus of the drawing of Orson 
Lowell depicting Jean Guiou (Guyon) du 
Buisson, one of Giffard’s principal tenants, 
carrying out the formal act of homage be­
fore Giffard’s representative following settle­
ment of some litigation (Fig. 4). It provides
an interesting insight into the practices of 
French feudal law.
Rene Goupil
A prime role was thus played by two of 
the early apothecaries and surgeons in rela­
tion to the colonization of New France in 
an era when havoc was wrought upon the 
settlers by those cruel and bitterly cold 
winters. However, the climate was not their 
only antagonist in their struggle for survival. 
The Indian, or peau-rouge as he was called, 
proved to be a formidable foe. The tragic 
story of Rene Goupil is only one of many 
that could be used to illustrate this point. 
Goupil9’ 19 was already a Paris surgeon 
when he entered the Jesuit order as a novi­
ciate in 1639. Subsequently, because of 
deafness, he was forced to discontinue his 
noviciate but he continued his association 
with the order as a donne. In 1640 he was
Fig. 4.—Formal act of homage before seigneu- 
rial manor of Robert Giffard at Quebec. (Repro­
duced by permission from Abbott ME: History 
of Medicine in Province of Quebec, Toronto, 
Macmillan, 1931.)
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living in Quebec. At the Jesuit mission there 
his surgical skills were much appreciated. 
In the summer of 1642 he set out for Hu­
ron country in the company of one of the 
Jesuit fathers, Isaac Jogues, another donne, 
and a band of friendly Indians, intent on 
making his surgical skills available in that 
isolated area. On Aug. 22 they were at­
tacked by the Iroquois and Goupil was taken 
prisoner. After 6 weeks of the most horri­
fying torture he was killed by a blow on the 
head from a tomahawk. His martyrdom was 
witnessed and reported by Father Jogues. 
He is venerated as the first Jesuit martyr in 
Canada and was canonized by Pope Pius 
XI in 1930. The practice of medicine was 
indeed hazardous in New France in the 17th 
century.
Etienne Bouchard
Etienne Bouchard, a surgeon from Paris, 
demands inclusion in our narrative for yet 
another reason. In 1655 he introduced the 
first prepaid medical program in Can­
ada.9’ 16’ 20 Bouchard came to Montreal 
in 1653 under agreement to La Societe 
Notre-Dame de Montreal. Two other sur­
geons arrived in Montreal at the same time, 
which may have contributed to Bouchard’s 
decision to initiate negotiations that led to 
the termination of his contract. He then 
completed an agreement with 26 heads of 
families in that city “to treat and supply 
with medicines themselves, their wives and 
families, both born and to be born” in re­
turn for 100 sous for each person so 
treated.9 Nadeau20 provides us with a some­
what different version of the method of 
payment. He suggests that Bouchard re­
ceived “ 100 sous paid annually in two in­
stalments by each settler”. Unfortunately 
Ahern11 is completely silent in respect to 
this aspect of Bouchard’s practice. In any 
case the contract, complete with exclusions, 
is amazingly similar in general terms to 
many available today. The only real differ­
ence is the modest price.
*  *  *
One might, with some justification, be 
critical of the foregoing as medical history 
and consider it rather as contributions to 
general history by practitioners of medicine
in the broadest sense. However, this com­
plaint could hardly be levelled at two dis­
tinguished medical scientists who exemplify 
the corporate reawakening of scientific 
thought in the latter part of the 17th and 
early 18th centuries — Michel Sarrazin and 
Jean-Frangois Gaultier.
Michel Sarrazin
The life of Michel Sarrazin has been 
briefly summarized in a previous issue of 
this journal by Caron,14 while Abbott,9 
Ahern,11 and Rousseau21 have provided 
us with fairly extensive accounts of his con­
tributions to medicine and science. In addi­
tion a small book written by Vallee,22 de­
voted entirely to this Canadian pioneer, is 
available. However, he emerges as the first 
real scientist in New France and, as such, 
it is appropriate to review briefly his career 
and accomplishments.
Sarrazin was born in 1659 at Nuits-sous- 
Baune in Burgundy and first came to New 
France in 1685 as a surgeon to the marine 
corps. During his initial stay of 9 years he 
achieved an enviable reputation for surgical 
skill, but there was no suggestion, during 
this period, of the major contribution that 
he was to make in a variety of spheres in 
later life. Apparently towards the end of 
this period he became ill and went through 
a period of depression, during which he at­
tempted to enter the priesthood. Fortunately 
for the history of medicine in this country 
the superior general of the Sulpicians re­
ported, “The more we have examined both 
his present and past state of mind, the more 
we have been convinced that there was no 
indication of a divine vocation to justify this 
change.”21 He was therefore advised to 
resume his former occupation. At this point, 
in 1694, he returned to France and enrolled 
in the medical faculty at Reims. During his 
studies he manifested a particular interest 
in botany and this was to provide him with 
an avocation at which he achieved distinc­
tion equal to that which he achieved as a 
surgeon. He received his bonnet in 1697 
and returned to Canada the same year.
Sarrazin’s preparatory studies were car­
ried out at l’Ecole de Medecine de Paris 
and the associated Hopital de l’Hotel-Dieu. 
Abbott9 gives us some insight into the im­
pact of such an experience.
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To understand the tremendous intellectual im­
petus which a University training in Paris at that 
time must have brought to this mature student, 
whose mind had been sharpened by hard-won 
experience, one must recall the immense changes 
that were taking place in medical thought at that 
time. The cognate sciences of physiology and 
pathology had been founded through the labours 
of Harvey and others, while the English clinician 
Sydenham, who died in 1689, had, by his power 
of observation and method of delineation of 
disease entities, brought these new found prin­
ciples to a focus in the great science of clinical 
medicine. LTcole de Medecine itself was full of 
eager disputation of the new ideas that were 
trembling in the air; and two great scientific 
institutions allied to medicine and ministering to 
its advancement, both of which became to Sar- 
razin an avenue and source of inspiration for his 
future activities, were being actively fostered un­
der the paternal government of Louis XIV. These 
were: the Jardin Royal des Plantes . . . and the 
Academie Royale des Sciences, founded by Col­
bert in 1666 and reorganized in 1699.
As a result of his activities in the field of 
botany and zoology Sarrazin was named a 
corresponding member of the academie in 
1699, the same year that Sir Isaac Newton 
was similarly honoured.
In addition to making an enormous con­
tribution as a naturalist, Sarrazin continued 
to give devoted service to the practice of 
medicine. Also, although now a physician, 
he continued to combine this with the prac­
tice of surgery in spite of the prejudice 
against such activity, at least in France it­
self. On his return to the colony in 1697, 
he was immediately appointed to the staff 
of l’Hotel-Dieu, and his devoted service dur­
ing the recurrent devastation that accom­
panied a series of serious epidemics — 
typhus, influenza, smallpox and yellow 
fever — has been recorded. He also appears 
to have achieved a degree of success in their 
treatment that was unusual for that period. 
In 1700 he was officially appointed King’s 
Physician and became the senior medical 
representative in the entire colony.
Sarrazin enjoyed equal success, and 
achieved much distinction, as a surgeon. 
In 1700, long before the birth of either 
Pasteur or Lister, or the introduction of 
anesthesia, he successfully performed a 
breast amputation on Sister Marie Barbier 
de l’Assomption.23 Although we are told 
that the lesion was a cancer she lived, in 
excellent health, for 19 years after her 
surgery. The records of l’Hotel-Dieu de
Fig. 5.—Pitcher plant (Sarracena purpurea), 
floral emblem of Newfoundland (courtesy of the 
Department of tourism, Government of N ew ­
foundland and Labrador).
Quebec report that he performed this oper­
ation on at least two other occasions as well 
as numerous other procedures that, at the 
time, would be considered major surgical 
undertakings.
As a botanist Sarrazin submitted innumer­
able specimens (over 200 in 1704 alone) 
of the flora of Canada to the Jardin Royal 
des Plantes through Tournefort, and later 
Reaumur, through whom he “corresponded” 
with the academie. These were accompanied 
by meticulous notes as to their care and the 
natural conditions of their growth. His de­
tailed description of the “pitcher plant” 
(Fig. 5), the floral emblem of Newfound­
land, led Tournefort to name it Sarracena 
purpurea after him. He also was responsible 
for the industrialization, if not the discovery, 
of maple syrup, the recognition and popu­
larization of the blueberry as an edible fruit, 
and, in addition, has his name associated 
with Indian corn or maize, which is com­
monly referred to as Sarracen corn.
As a zoologist he dissected, and prepared 
detailed descriptions of the anatomy of, 
many of Canada’s native animals, including 
the muskrat, the beaver, the porcupine and
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even the bear and the caribou. One record 
is, however, incomplete — that of his dis­
section of a skunk. Of his experience he 
wrote, “It had a dreadful smell, capable 
qf making a whole canton desert.”0 The 
accuracy of his minute description of the 
features of the organs of these animals is 
all the more amazing when one realizes that 
his instruments included only a surgical dis­
secting set and a hand lens. Many of his 
submissions were published in the reports of 
the academie and have been preserved.
Sarrazin died in 1734 at the age of 75. 
His major administrative achievement, apart 
from his appointment as King’s Physician, 
was his appointment to the Conseil Supe- 
rieur de Quebec in 1707. However, it is as 
an outstanding physician and surgeon and 
as a distinguished botanist and zoologist that 
he deserves our study. One should remem­
ber, too, that major difficulties attended the 
pursuit of these objectives in Canada be­
tween 1685 and 1734. These difficulties can 
hardly be expressed more effectively than in 
Sarrazin’s own words:* “I do not know 
whether it is believed that one botanizes 
in Canada under the same conditions as in 
France. I could more easily traverse the 
whole of Europe, and with less danger, than 
I could cover 100 leagues in Canada, a 
much riskier undertaking.”21
Although Caron14 has provided us with 
a picture of Sarrazin, Rousseau21 is of the 
opinion that no authentic likeness is known 
to exist and believes the often displayed 
photograph to be rather that of a French 
doctor of about the same period.
Jean-Frangois Gaultier
Although of different temperament and 
personality we find a worthy successor to 
Sarrazin in Jean-Fran§ois Gaultier.0- 24 
There is also a remarkable parallelism in 
their careers. Gaultier was, however, a physi­
cian and a doctor of medicine and had never 
been a surgeon. Like Sarrazin, he was 
named King’s Physician in Canada (1741), 
and was appointed to the Conseil Superieur 
of the colony in 1744. In addition he was
♦Included in a letter to Reaumur in 1726 and 
published as an appendix in Vallee’s book;22 also 
included, in translation, by Rousseau.21
named a corresponding member of the Aca­
demie Royale des Sciences of Paris in 1745, 
reporting through Duhamel du Monceau.
Gaultier arrived at Quebec in 1742. He 
immediately profited as a result of the 
pioneering botanical efforts of Sarrazin and 
the interest of the temporary governor 
Galissoniere and. was able to achieve an 
effective organization for the collection of 
specimens throughout the colony. Kalm, 
whom Gaultier assisted with his botanical 
studies in Canada, recognized the latter’s 
indispensable assistance by dedicating the 
genus Gaultheria to him. Although the genus 
includes some 150 species of wide geo­
graphic distribution, the best known medi­
cally is certainly Gaultheria procumbens, 
from which oil of wintergreen is obtained. 
Gaultier continued to send shipments of 
plants, accompanied by voluminous notes, 
to the French academie. However, even to­
day, the significance of his personal con­
tribution to botany remains to be assessed 
since only a small portion of his manuscripts 
have been published and the remainder, 
many of them only recently rediscovered, 
have never been critically assessed.
Rather than zoology it was meteorology 
that was Gaultier’s second, or perhaps it 
should be considered his prime, nonmedical 
scientific avocation. In 1742 he set up Can­
ada’s first meteorologic station. His log 
runs from that date to 1756 and was, in 
part, published by Duhamel du Monceau 
in the memoires of the academie. Unfor­
tunately Gaultier’s observations in this re­
gard, like his botanical reports, have never 
been critically analyzed and their true sig­
nificance is therefore a matter of conjecture. 
In his meteorologic reports he did, however, 
include much valuable comment about life 
in the colony.
Since the archives of l’Hotel-Dieu de 
Quebec were destroyed in a fire in 1755 
we know little directly of Gaultier’s medical 
practice. However, his meteorologic reports 
contained a monthly bulletin on the state 
of the health of the colony including the 
frequency of various diseases and the reme­
dies prescribed in their treatment. A partial 
list of some of the medicines used was given 
by Boivin.24 He encouraged the use of 
wintergreen tea and tested the antiscorbutic
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properties of the spruce tree, recommending 
spruce beer in treatment of scurvy.
Gaultier has been characterized as an 
encyclopedist and as a scientist who effec­
tively performed the responsibilities assigned 
to him but who lacked the aggressive self- 
motivating scientific spirit of Sarrazin. It is, 
however, perhaps too early to pronounce 
this verdict since the evidence is far from 
completely evaluated. In any case he was 
apparently respected and beloved by his 
patients and compatriots. Like so many of 
his fellow practitioners who succumbed to 
one or other of the epidemics of those days 
he died at a young age (48 years) of typhus, 
which was brought to the colony in 1756 
by the ship Leopard, a part of the squadron 
that brought Montcalm to Canada.
* * *
Seven medical practitioners, five of them 
surgeons, have been selected to highlight 
various facets of Canadian medical practice 
during the French regime. Each had an 
avocation apart from medicine and it is this 
that has dictated their inclusion. However, 
all, according to the standards of their day, 
appear to have enjoyed and amply justified 
the respect and confidence of the other 
colonists in their role, be it as surgeon, 
apothecary or physician. One should there­
fore perhaps close by re-emphasizing that 
not all those who bore such designation in 
New France were of the calibre of this 
group and, in fact, many were downright 
charlatans and quacks. At a somewhat later 
date (1784) James Fisher speaking of Que­
bec wrote:
I cannot help thinking, but that medicine, as it 
is now practised in Canada, is materially injurious 
to Population and, I do aver, that although many 
Individuals are indebted to it for their lives and 
the health they enjoy yet if we take the Province 
at large, it would contribute to the increase of 
His Majesty’s subjects were there not one of the 
Oesculapian tribe in this part of British Amer­
ica.25
Fisher may well have overstated his indict­
ment intentionally to achieve greater em­
phasis, but there is little doubt that the 
individuals who practised medicine in Can­
ada during the French regime represented 
the complete spectrum of medical ability 
and ethical standards from the very best to
the very worst. About all they had in 
common were the harsh realities of the bit­
ter winter climate and the ever-present dan­
ger of sudden death from some plague or 
at the hand of their indomitable foe, the 
Iroquois. Whatever their strengths and 
weaknesses they are part of our heritage 
and we would do well to come to know 
them.
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permitted on the understanding that the candidate shall be the first author and 
that only the first author shall be eligible for the award.
3. Entries must be received in the office of the Journal no later than June 30, 1977. 
Each entry must be submitted to E. M. Cooperman, MD, FRCP[C], at the 
office of the Canadian Journal of Surgery, PO Box 8650, Ottawa, Ont. 
K1G 0G8, with a letter stating that the paper is being submitted as an entry 
for the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property of the Canadian Journal of Surgery 
unless returned to the author without publication.
All papers submitted will be judged by an independent committee comprising at 
least one member of the editorial board of the Journal, one fellow of the Royal College 
of Physicians and Surgeons of Canada, and one representative of The Canadian Medical 
Association, together with other fellows invited to serve at the discretion of the three 
permanent members of the committee. For the purpose of judging, the candidates will 
be anonymous. The judges’ decision shall be final.
The name of the successful candidate and the title of the paper will be announced 
in the November 1977 issue of the Journal.
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CORRESPONDENCE
EXTRAUTERINE PREGNANCY
To the editor: The account by M. B. Quane 
of a patient with an extrauterine pregnancy 
that was diagnosed at 10 weeks and allowed 
to continue until term {Can J Surg 19: 359, 
1976) makes some interesting points about 
the causes and management of this rare 
occurrence. All those concerned deserve 
congratulations on the successful outcome 
of this particular pregnancy, and both pa­
tient and obstetrician get full marks for 
courage.
But it is to be hoped that Quane’s paper 
does not inspire others to follow his example. 
It is most unusual for an extrauterine preg­
nancy to be so situated that it can continue 
until the fetus is viable with reasonable 
safety to the mother. A “tangerine-sized 
solid mass of limited mobility in the region 
of the left appendage” palpated beside a 
soft, slightly bulky uterus at 10 weeks’ gesta­
tion, is much more likely to indicate an 
ectopic pregnancy in the interstitial portion 
of the fallopian tube or in an incompletely 
developed uterine cornu. In either case 
rupture with massive hemorrhage will almost 
certainly occur some time during the 1st or 
2nd trimesters, and may be fatal.
The team I had the privilege of working 
with in Jamaica managed ectopic pregnan­
cies of virtually every type. We adopted the 
aphorism “an ectopic unopened is an ec­
topic mismanaged”. There are rare excep­
tions, as in Quane’s case, but they are few 
indeed.
D. B. STEWART, FRCS[C], FRCOG
Formerly professor of obstetrics 
and gynecology,
University of the West Indies,
Jamaica, WI.
Present address:
Box 805,
Killarney, Man.
CRITIQUE OF ITEM 509 (SESAP II)
In the diagnosis of carcinoma of the colon, carcinoembryonic antigen (CEA) has 
not proven as beneficial as original reports suggested. Response (4) is incorrect: 
the procedure has not provided a useful screening test for the discovery of new 
cases of colon carcinoma because the antigen is nonspecific. However, response (1) 
is proper: the presence of increased levels of CEA is highly suggestive of the pres­
ence of further carcinoma in patient who has had a bowel resection for carcinoma 
of the colon. Measuring CEA periodically in these individuals is one valid method 
of follow-up. Unfortunately, elevated levels of CEA have been found in patients 
with sigmoid diverticulitis and in certain individuals with collagen diseases; there­
fore response (2) and (3) are also correct.
Reference
509/1. Lebel JS, Deodhar SD, Brown, CH: Newer concepts of cancer of the colon 
and rectum: Clinical evaluation of a radioimmunoassay for CEA. Dis Colon Rec­
tum 15:111-115, 1972.
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B O O K  R E V I E W S
ANGIOGRAPHY OF POSTERIOR FOSSA
TUMORS. Samuel M. Wolpert. 196 pp.
Illust. Grune & Stratton, Inc., New York;
Longman Canada Limited, Toronto, 1976.
$27.00.
The posterior fossa is one of the more difficult 
areas in neuroradiology to investigate angio- 
graphically; in spite of this the author has 
succeeded in presenting the subject in a clear 
concise manner.
A brief introduction to the history and 
techniques of posterior fossa angiography is 
followed by chapters depicting normal angio­
graphic anatomy and altered anatomy pro­
duced by intra- and extra-axial mass lesions. 
A series of coloured plates are used to illus­
trate the normal relation of arteries and veins 
to the cerebellum and brain stem and also the 
disturbed relations occurring in the presence 
of space-occupying lesions.
A chapter on the clinical and pathologic 
aspects of posterior fossa tumours adds per­
spective to the descriptions of vascular dis­
placements. The angiographic films are of 
superior quality; the vessels are clearly marked 
and easily identified. Several figures have been 
mislabelled; however, I understand that an 
erratum will be added to future printings. A 
good list of references conveniently follows 
each chapter.
Although computerized tomography has 
greatly facilitated the diagnosis of these mass 
lesions, posterior fossa angiography remains 
an excellent diagnostic procedure. This book 
is recommended to both residents and prac­
tising physicians in neurosurgery and neuro­
radiology.
P. W. Cooper
Department of radiology,
Sunnybrook Medical Centre,
Toronto, Ont.
ANORECTAL MALFORMATIONS AND  
ASSOCIATED DISEASES. Progress in 
Pediatric Surgery. Volume 9. Executive 
Editors: P. P. Rickham, W. Ch. Hecker and 
J. Prevot. 154 pp. Illust. University Park 
Press, Baltimore, 1976. $19.50.
This is the ninth volume of the series “Pro­
gress in Pediatric Surgery”. The series has 
drawn from the experience of well-known 
pediatric surgeons around the world, and is 
authoritative and reliable throughout. This 
book is not for the undergraduate; it is de­
signed for the specialist in pediatric surgery, 
but many articles will be of interest to the 
pediatrician and general surgeon also.
Anorectal continence in the normal subject 
is discussed and problems such as the nerve 
supply to the large bowel and rectum, now 
not clearly understood, are touched upon. The 
pharmacology of neural impulse transmission 
and pharmacologic anomalies in the autonomic 
supply of patients with Hirschsprung’s disease 
are presented and the classic operations 
for the improvement of fecal incontinence in 
these patients are described.
The embryology of imperforate anus (IA) 
and the IA classification adopted in 1970 by 
the World Congress of Paediatric Surgery in 
Melbourne are discussed; descriptions of the 
clinical and radiologic determinants of the 
level and type of IA are excellent. The authors 
have provided clear descriptions of the opera­
tive modes most suitable for each of the 
three levels of IA; to ensure maximal con­
tinence they properly stress the necessity for 
adequate assessment and a proper operative 
approach.
The authors leave us with many stimulating 
questions and some solutions. The text is in­
tended for a select group but the style is 
clear and the material well presented.
S. Mercer 
Chief,
Department of surgery,
Children’s Hospital of Eastern Ontario,
Ottawa, Ont.
COMPUTED TOMOGRAPHY OF BRAIN 
AND ORBIT (EMI SCANNING). Paul F. 
J. New and William R. Scott. 486 pp. 
Illust. The Williams & Wilkins Company, 
Baltimore; Burns & MacEachern Limited, 
Toronto, 1975. $43.45.
This is the first complete text on computed 
tomography of the brain. Since its publication 
there have been notable technologic advances, 
with many scanners besides the EMI now 
available. Clinical experience has also grown 
extensively since publication. However, this 
book still has strong merits: the basic physical 
and clinical concepts are well presented and 
still apply. Figures are easily seen without 
having to turn pages to read their description. 
The index is well organized and complete.
Part one deals with the physical and opera­
tional aspects of the EMI scanner. Both the 
old 80 x 80 and the updated 160 x 160 ma-
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trices are discussed with an abundance of 
clear explanatory diagrams. The chapter on 
anatomic correlations is excellent. Numerous 
well-labelled brain slices are presented with 
the appropriate level of scan; and the appear­
ance of normal structures is described in 
detail, including changes with various scanning 
angles.
Part two (about 75% of the text) consists 
of an atlas of pathology. Most of these scans 
are of the old 80 x 80 matrix. However, this is 
less of a problem than would be expected 
since the scans are quite free of artefacts, and 
are particularly well selected to illustrate 
clearly the abnormality. The range of patho­
logic entities included is quite complete and 
the basic appearance of lesions has not 
changed appreciably in spite of the rapid ad­
vances in this technique. Correlation of the 
clinical history, angiogram, pneumoencephalo­
gram and the nuclear scan is excellent. In the 
chapter on the orbits use of the old 80 x 80 
matrix detracts from the quality of the illus­
trations.
In spite of the limitations, since the text 
encompasses all the aspects of computed tomo­
graphy scanning in a single unified source, it 
is still useful reading for those interested in 
learning the basic physical and clinical 
aspects of this revolutionary diagnostic aid.
S. T aylor
Montreal Neurological Institute,
Montreal, PQ.
GASTROINTESTINAL EMERGENCIES.
The Thirty-Fourth Hahnemann Symposium.
Edited by Harris R. Clearfield and Vicente
P. Dinoso, Jr. 295 pp. Illust. Grune &
Stratton, Inc., New York; Longman Canada
Limited, Toronto, 1976. $31.25.
Books dealing with emergencies are similar to 
oral contraceptives in that they are most suit­
ably employed before the event. None the less, 
“Gastrointestinal Emergencies” is a useful 
volume, even if taken as a morning-after pill.
Unlike most published symposia this is a 
well-organized publication and clearly describes 
the problems associated with most of the gas­
trointestinal emergencies. The book includes 
sections on upper gastrointestinal hemorrhage, 
hepatic emergencies, mesenteric vascular dis­
ease, diverticular disease, acute colitis and 
pancreatitis. The final section deals with acute 
diarrhea, intra-abdominal hemorrhage, com­
plications of radiologic investigations and 
management of complications resulting from 
the ingestion of corrosive agents. Most sec­
tions begin with a chapter reviewing the patho­
genesis of the emergency problem to be dis­
cussed. Consideration of the diagnosis is 
followed by a description of the proper man­
agement. Each chapter is adequately refer­
enced; the overall length of each is less than 
10 pages. The organization and brevity of this 
book combine to make it a handy reference 
during an actual hospital emergency and a 
painless bedtime refresher course.
There are criticisms, of course. The many 
printing, spelling and grammatical errors are 
annoying. Most topics are dealt with in an 
even-handed way; however, the statement in 
chapter 22 that one third of patients with toxic 
megacolon may be successfully managed with­
out surgery is not generally accepted and the 
presentation in chapter 23 of one centre’s 
unorthodox surgical approach to toxic mega­
colon is inappropriate and detracts from the 
overall merit of the book. It is stated in chapter 
18 that 5% of patients with diverticular dis- 
sease require operation for hemorrhage. This 
is an overstatement. Aggressive use of angio­
graphy in the investigation of gastrointestinal 
hemorrhage and mesenteric vascular disease is 
advocated; this approach, if worthwhile, is 
impractical at many centres.
This book is valuable as a prophylaxis 
against the mishandling of gastrointestinal 
emergencies; the palatability of the medicine, 
however, may be impaired by the price.
W. G. T hom pson
Associate professor of medicine,
University of Ottawa,
Ottawa Civic Hospital,
Ottawa, Ont.
HUMAN NEUROANATOMY (Formerly
Strong and Elwyn’s Human Neuroanatomy).
7th ed. Malcolm B. Carpenter. 741 pp.
Illust. The Williams & Wilkins Company,
Baltimore; Burns & MacEachem Limited,
Toronto, 1976. $27.50.
It is a pleasure to read a text that is so com­
prehensive, lucid and current; both the author 
and the publisher are to be congratulated. 
Discussion of the tracts of the spinal cord and 
the thalamus (diencephalon) are especially ex­
tensive. Primarily directed at students, the 
rather crowded text calls for creation of open 
space by more subheadings, which would also 
eliminate redundancies as in the descriptions of 
nigral efferent fibres. It would be further re­
lieved by more original diagrams, especially in 
the section on the functional anatomy of the 
brain stem.
There is no account of structure, innerva­
tion or functional attributes of the cerebral
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vessels — a topic of major clinical importance. 
Less important omissions include accounts of 
the recently defined membrane properties of 
neuronal soma and dendrites; the distribution 
of callosal fibres; the internal organization of 
autonomic ganglia; the likely roles of the 
striatum in conditioning; likely roles of the 
posterior commissure in split-brain patients 
and callosal agenesis. Minor apparent incon­
sistencies concern the blood supply of the an­
terior thalamus (pages 605 and 616), the 
innervation of the pineal gland (usually con­
sidered to be sympathetic only) and direct 
efferent fibres from the visual cortex (more 
likely from areas 18 and 19). Rare misleading 
constructions such as “the ependyma contri­
butes to the CSF” (rather than the extracellular 
fluid through the ependyma) or word confu­
sions (neurotubule for microtubule) were seen.
The minor or even debatable nature of most 
of these criticisms merely serves to underline 
the high quality of the factual content. The 
volume is of reasonable size and is well bound, 
and the illustrations are good to excellent; 
colour reproduction is only adequate. As in the 
section on the cerebral cortex, correlation of 
text and figures could be better. The small 
number of grammatical errors (fewer than a 
dozen and all minor) speaks well for the copy­
editing.
This text is highly recommended for med­
ical students. It will also be of continuing value 
to residents and practising physicians in all 
neurologic specialties.
A. J. Lewis
Associate professor,
University of Ottawa,
Ottawa, Ont.
MANUAL OF SURGICAL NUTRITION. 
American College of Surgeons Committee 
on Pre and Postoperative Care. 527 pp. 
Illust. W. B. Saunders Company, Philadel­
phia; W. B. Saunders Company Canada 
Limited, Toronto, 1975. $19.05.
Among the 36 contributors to this book are 
many of the most knowledgeable persons in their 
respective fields. The book opens with a brief 
but complete chapter on the history of nutri­
tion. This is followed by a section on the basic 
science of nutrition and another on the applica­
tions of this knowledge to the practice of 
clinical surgery. An extensive appendix pro­
vides representative samples of diets and diet­
ary supplements. Special attention to proper 
nutritional care is necessary for the survival
of many surgical patients; this book goes a 
long way in providing appropriate guidelines to 
this kind of nutritional care.
The basic science section is divided into 
three parts; these are very detailed excellent 
reference sources. Part 1 comprises a discus­
sion on the metabolism of carbohydrates, fats 
and proteins, and salt, water and vitamins. In 
part 2 the sources and utilization of energy 
are discussed; the chapter on the absorption 
of nutrients, because of its clarity, deserves spe­
cial note. Part 3 deals with the response to 
starvation and stress.
In part 4 all the available techniques for 
enteral and parenteral feeding are presented. 
The authors then discuss the indications for 
particular methods. Specific attention is drawn 
to the applications of this information in pedia­
trics, surgical infection, malignant disease and 
organ failure syndromes. One chapter entitled 
“Intestinal Fistulas and Malabsorption”, 
although accurate and informative, would have 
achieved its purpose better if the subjects were 
divided; another devoted to a surgical approach 
to the management of morbid obesity is topical 
and especially interesting.
This is a well-organized, excellent reference 
book for both the surgeon and the gastro­
enterologist. There are many books on surgical 
nutrition, but this is by far the best.
M. Deitel and M. A. Alexander
St. Joseph’s Hospital and University of Toronto, 
Toronto, Ont.
VENOUS SURGERY IN THE LOWER EX­
TREMITIES. Chief Editor: Kenneth G.
Swan. 442 pp. Illust. Warren H. Green,
Inc., St. Louis, 1975. $32.50.
This monograph is made up of a series of 
manuscripts presented for a symposium on 
venous surgery in the lower extremities at the 
Walter Reed Army Institute of Research. Most 
of the manuscripts discuss the results of ex­
perimental surgery.
The importance of repairing major veins of 
the extremities at the time of arterial, ortho­
pedic and other reconstructive procedures is 
stressed. After reviewing recent war experi­
ence, the authors conclude that the amputa­
tion rate decreases if venous injury is not 
delayed but is repaired along with associated 
arterial injury.
In a series of clinical and experimental 
studies, it was clear that in venous replace­
ment autogenous grafts must be used; the
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operative technique must be error-free and 
the suturing meticulous. A synthetic prosthesis 
can be used for bypass in the innominate vein 
and superior vena cava. Heparin is recom­
mended for anticoagulant therapy. Operative 
venography is reliable and follow-up veno­
graphy during the first 6 weeks is recom­
mended.
The authors describe a variety of nonin- 
vasive methods for measuring peripheral blood 
flow; those most likely to become practical 
within the next few years are described. The 
description of the pathophysiology of arterio­
venous fistulas is adequate.
More experimental surgery is required to 
help solve the problems associated with venous 
and arterial thrombosis. It is not understood 
why arterial thrombosis resulting in occlusion 
is usually compensated in time by collateral 
circulation while after venous thrombosis, the 
thrombosed vessels themselves usually recana­
lize. Enzymatic dissolution of clots in clinical 
practice requires more investigation and 
development; some experimental work is de­
scribed. Streptokinase and urokinase are the 
most promising plasminogen activators.
The discussions following the papers are 
excellent. Because most of the presentations 
are based on experimental work, the publica­
tion will be of greatest interest to the experi­
mental and vascular surgeon. It is recom­
mended for trainees in vascular surgery.
R. H. Craig
Chief of surgery,
Grace Hospital,
Ottawa, Ont.
PRACTICAL CRYOSURGERY. Edited by 
H. B. Holden. 168 pp. Illust. Pitman Med­
ical Publishing Co. Ltd. Distributed by Year 
Book Medical Publishers, Inc., Chicago, 
1975. Price not stated.
This book is timely and concise. The author 
describes both the advantages and the dis­
advantages of cryosurgery in each specific field 
where it is used.
The book opens with a short but excellent 
review of the history and development of this 
treatment modality; this is followed by an 
authoritative chapter on the practical aspects 
of cryosurgical engineering. Unfortunately a 
list of the manufacturers of the equipment 
described is not included.
In the rest of the book the author describes 
the application of freezing techniques to each 
specific field.
Applications in ophthalmology were most
interesting; here, cryosurgical techniques are 
being used in the management of both com­
mon and uncommon eye diseases such as 
intraocular and extraocular eye tumours. The 
most notable use of cryosurgery in ophthal­
mology has been the treatment of herpes 
keratitis in conjunction with immunotherapy.
The use of cryosurgery to achieve hemostasis 
is a fundamental property of the technique. 
This application is well illustrated in the 
chapters on the treatment of head and neck 
lesions.
The applications of cryosurgery to the treat­
ment of specific lesions arising in the practice 
of gynecology, urology and general surgery 
are well illustrated; the applications described 
for neurosurgery have been made known 
because of the pioneering work of Dr. Irvine 
Cooper.
This book is worth while and highly recom­
mended for those interested in learning the 
uses and applications of cryosurgery in all of 
the surgical specialties.
H. R. Shibata
Department of surgery,
Royal Victoria Hospital,
Montreal, PQ.
DIRECTOR
MULTI-DISCIPLINARY INTENSIVE 
CARE UNIT
The Hospital
The Calgary General Hospital is a modern 928-bed 
active treatment hospital. It is affiliated with The 
University of Calgary, and conducts graduate and 
under graduate training programs in all clinical 
departments.
The Position
This w ill be a fu ll time appointment and the Director 
would be responsible for overall direction of the 
unit; consultations to the Medical Staff; education 
of physicians, residents and para medical personnel; 
and various administrative duties.
The Candidate
The successful candidate w ill be a certified spe­
cialist in internal medicine, surgery or anesthe­
siology, or one of the sub specialties thereof, and 
w ill be eligible for licensure in Alberta. Experience 
in critical care medicine is essential, and the candi­
date should also have abilities in development of 
patient care programs, teaching and administration.
Please apply by sending a complete curriculum vitae to: 
M r. A. J. Maiani 
Associate Executive Director 
CALGARY GENERAL HOSPITAL 
841 Centre Avenue East 
Calgary, Alberta T2E 0A1
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